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1. INTRODUCTION: TRENDS IN CANCER CONTROL
The Australian population experiences a life time risk of cancer (excluding 
non-melanocytic skin cancers) to age 75 of about 1 in 4. Cancer is the 
second most common cause of death, after circulatory disease. In 1992, in 
Australia, 32,003 deaths due to cancer were registered, representing 26% of 
all deaths (Australian Institute of Health & Welfare, 1992). Crude incidence 
and mortality rates of cancer have risen in Australia over the past 3 decades. 
Much of this increase is due to the increasing age of the Australian 
population (National Goals and Targets Report, 1994).
Although crude cancer mortality rates increased between 1985 and 1992, the 
age standardised mortality rate from cancer actually fell by about 5%. There 
has also been a consistent improvement in cancer case survival rates over 
the past 14 years observed in South Australia, where these data are 
available (SA Health Commission, 1994). It would seem reasonable to 
assume the same trend would be followed throughout the remainder of 
Australia. Similar changes in case survival rates have been reported from 
the United States (Boring etal., 1992).
The large burden of morbidity and mortality endured by the community due to 
cancer has lead to the identification of cancer control as a priority health 
issue in Australia (National Goals and Targets Report, 1994). The aetiology 
of a number of important cancers is clearly associated with environmental 
and life style factors such as smoking. A major goal will remain primary 
prevention through behaviour modification and environmental control. 
Secondary prevention requires the early diagnosis of malignant or pre- 
malignant lesions. Screening programs have been extended for cancers, 
such as breast cancer, where these programs are useful. Despite these 
initiatives, cancer incidence is projected to rise further. Ever increasing 
numbers of patients with cancer can be expected to present for care and 
treatment. Thus, improvements in cancer therapy are needed to increase 
cancer control rates. Some of these improvements may help to contain the 
economic cost of the disease. Improved cancer treatment, and particularly 
improvement in the associated supportive care, is central to maintaining the 
quality of life of people who develop cancer. As will be discussed, safe and 
simple methods of obtaining repeated access to the circulatory system of 
patients under clinical care have become crucial in permitting optimal cancer 
care.
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2. THE INCREASING REQUIREMENT FOR VASCULAR 
ACCESS
Cancer survival rates have slowly improved over the past 20 years. The 
factors underlying this improvement are difficult to measure, however 
improved outcomes from medical treatment are likely to be important.
Improved and earlier diagnosis is also likely to be important. Approximately 
60% of internal malignancies are cured with currently available therapeutic 
interventions. Modern cancer care incorporates the use of the three main 
modalities of cancer treatment, that is, surgery, radiotherapy and 
chemotherapy often in a combined approach.
Vascular Access in Cancer Surgery and Radiotherapy
Developments in surgical practice have enabled more effective cancer 
surgery to be performed with less morbidity. As the scope of new surgical 
techniques in fields such as reconstructive surgery have developed, the 
complexity of the requisite supportive care has increased. This supportive 
care is essential in permitting new surgical treatments to be successfully 
applied. Prolonged intravenous access is a feature of the intensive care 
which supports the surgical patient with cancer. The efficacy of parental 
nutrition in preventing surgical complications in patients undergoing surgery 
for advanced cancer is well established. Semi-permanent central venous 
catheters are an essential component of most parenteral nutrition programs.
In radiotherapeutic practice the development of infusional schedules of 5- 
flourouracil, cisplatin, and other chemotherapeutic drugs which may act as 
radio-sensitising agents has been an increasingly applied technique 
(Sugarbaker et al., 1985). The concomitant infusion of 5-flourouracil with 
radiotherapy has been shown to improve response rates, compared to 
radiotherapy alone, in the treatment of carcinoma of the cervix, anal canal, 
and oesophagus. Active investigation of this approach is continuing and the 
application of this and similar forms of treatment is likely to expand as 
efficacy is demonstrated (for example Leichman et al., 1993). Such 
combined modality programs need prolonged and durable venous access. 
Semi-permanent central venous catheters have facilitated the development of 
this therapeutic approach.
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Chemotherapy and Vascular Access
Since the initial trial of nitrogen mustard chemotherapy for Hodgkins disease 
in 1943 more than 30 anti-cancer cytotoxic agents have entered regular 
clinical use. It has been estimated that more than 250,000 people with 
cancer are treated annually in the United states with cytotoxic chemotherapy 
(DeVita 1985). Almost all of this treatment is given by injection, usually by 
intravenous infusion. Providing the means for physically administering this 
therapy as well as providing a route to facilitate the associated supportive 
care has lead to a steady increase in the use of semi-permanent intravenous 
devices.
Continuing attempts are being made to maximise the cancer control rate with 
the currently available chemotherapeutic drugs. Strategies have included the 
use of combinations of drugs to take advantage of possible synergism and to 
prevent the development of tumour cell resistance (Scanlon & Nee Dels, 
1986). More complex drug combinations and schedules, and the associated 
supportive treatment, transfusions and antibiotics, have led to the more 
frequent use of semi-permanent catheters. A steady increase in the 
frequency of Hickman catheters in patients with predominantly 
haematological malignancy has been reported from an Australian hospital 
over a recent 7 year period (Gibson et a/., 1994).
More recently the relationship between dose intensity and control rates have 
been examined. Higher dose intensity has been associated with better 
control rates in studies of breast cancer, lymphoma, and acute leukaemia 
(Hryniuk et at., 1986). Dose intensity may be increased with the application 
of intensive supportive care such as autologous peripheral stem cell 
infusions.
Autologous bone marrow transplantation and the related procedure of 
autologous peripheral stem cell infusion are methods allowing the use of very 
dose intense chemotherapy. Patients undergoing these procedures require 
intensive supportive care. Semi-permanent central venous catheters are 
universally required for these procedures. The final place these forms of 
treatment will have in the management of common haematological and solid 
malignancies remains unclear, however 333 autologous bone marrow 
transplants were performed in Australia in 1993 (Atkinson & Szer, 1994). 
Semi-permanent central venous catheters may be used both for the
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cytophoresis procedure where peripheral blood stem cells are collected and 
for the high dose chemotherapy and related supportive care.
Allogeneic bone transplantation is now an established treatment for various 
forms of leukaemia and other haematological disorders. The number of 
transplants performed world wide has risen steadily to over 5000 per year in 
1990 (Borton et at., 1992). Such procedures lead to the requirement for a 
prolonged period of very intensive supportive care during which semi­
permanent central venous catheters are ubiquitous. The insertion of some 
form of central venous catheter is mandatory in most transplantation centres 
at the beginning of the procedure (Flowers & Sullivan, 1994).
Continuous Infusional Chemotherapy
The administration of cytotoxic chemotherapeutic drugs as a continuous slow 
intravenous infusion has been developed as a way of increasing dose 
intensity and efficacy. Cytotoxic drugs that are cell-cycle phase-specific in 
their action are suitable for this approach, particularly if they have a short 
terminal half-life.
Some cytotoxic drugs, such as 5-fluorouracil are clearly more efficacious in 
treating certain cancers, such as breast cancer, when given as a slow 
infusion (Anderson 1993). The use of continuous infusions of 5-fluorouracil 
in ambulatory patients has become feasible because of the availability of 
reliable semi-permanent catheter systems such as Hickman catheters (for 
example Jones et at., 1994). When used in this way, 5-fluorouracil is less 
myelosuppressive, and other forms of toxicity such as mucositis or diarrhoea 
become the dose limiting factors. Much higher dose rates are achievable 
with continuous infusions compared to conventional bolus administration 
(reviewed by Hansen, 1991).
An improved therapeutic index for slow infusional chemotherapy has been 
reported for bleomycin (Remick et at., 1994). Other cytotoxic drugs which 
may beneficially be administered as prolonged infusions include doxorubicin, 
cisplatin, and vinblastine. Many of the cytotoxic drugs currently being 
administered by slow continuous infusion are dangerous if extravasated. As 
with radiation sensitisers and bone marrow transplantation, the widespread 
inclusion of infusional therapy into therapeutic protocols has only become 
feasible because of the availability of safe methods of obtaining durable 
access to the central circulation.
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Economic issues and Venous Access
The development of moderately efficacious but ever more complex cancer 
treatment has had major cost implications. As supportive care has improved, 
complex therapeutic protocols have been able to be safely administered to a 
wider group of patients with cancer. The general application of what were 
once considered to be highly specialised investigational therapies will have 
continuing economic repercussions. While semi-permanent central catheters 
have had a permissive role in the penetration of these new complex protocols 
into more general clinical use, they may also provide a means of reducing 
cost in certain circumstances.
More robust methods of obtaining durable venous access have been 
important in permitting the transfer of an increasing proportion of care to the 
clinic and out of hospital wards. Patients with a semi-permanent central 
venous catheter, such as a Hickman catheter, in situ may have intravenous 
infusions and catheter care provided at home. Continuous intravenous 
infusions of cytotoxic drugs are routinely given through central venous 
catheters using a miniature pump worn or carried by ambulant patients at 
home. People requiring prolonged parenteral nutrition or intravenous 
antibiotic therapy are able to be given this therapy at home via a semi­
permanent central venous catheter (Pomp et a!., 1989; Mukau et a!., 1992).
The provision of intravenous therapy outside of traditional hospital facilities 
may represent an important improvement. The avoidance of hospital 
admissions for infusions improves the quality of life for the patients involved. 
A reduction in the number of hospital admissions would be expected to have 
economic benefits in terms of cost per patient cared for, depending on the 
cost structure of the health system in question. Studies are under way in 
Australia to assess the economic impact of home infusion chemotherapy 
programs (Prof R Kefford, personal communication).
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3. STUDY OF HICKMAN CATHETER USE IN WODEN 
VALLEY HOSPITAL: AIMS AND OBJECTIVES
Aims
To examine the pattern of use, duration of use and adverse events 
associated with use of Hickman catheters in the study population.
To explore the determinants of adverse events associated with Hickman 
catheter use within the study population.
Primary Objectives
To develop a predictive model for the risk of Hickman catheter failure as 
defined by removal of the catheter because of a complication.
To explore the determinants of catheter malfunction (as defined) with 
particular reference to the measured catheter tip position, the site of 
insertion, duration of catheter use, and the patient diagnostic group.
Secondary Objectives
To explore the determinants of Hickman catheter infection within the study 
population.
To explore the determinants of Hickman catheter migration or dislodgement 
within the study population.
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4. REVIEW OF METHODS FOR OBTAINING AND 
MAINTAINING VENOUS ACCESS
In this section an overview of methods in current practice for obtaining 
venous access is provided. Methods described include the simple peripheral 
intravenous cannula, non tunnelled central venous catheters, the tunnelled 
central venous catheters such as the Hickman and Groshong, and fully 
implanted subcutaneous ports. Different techniques of insertion of Hickman 
catheters are also discussed.
Peripheral Venous Catheters
Venous access has been traditionally obtained via peripheral veins using 
steel needles or polyethylene intravenous cannulas. Modern steel scalp vein 
needles continue to be used for short term venous access. Peripheral vein 
plastic cannulas are ubiquitous within hospital facilities in developed 
countries. These peripherally inserted cannulas are cheap and easy to 
insert. While ideal for short term use, peripheral venous catheters have 
many limitations. They are unsuitable for use with continuous infusions of 
irritant solutions, such as some anti cancer cytotoxic drugs, and parenteral 
nutrition infusate. Attempted infusion of such fluids into a small peripheral 
vein (with relatively low blood flow) causes local phlebitis. Peripheral vein 
cannulas frequently block or kink. The tip of the cannula can migrate to an 
extravascular site. The accidental infusion of some drugs, formulated for 
intravenous use, into the subcutaneous tissues due to a malfunctioning 
peripheral cannula (i.e. accidental extravasation) can lead to loss of efficacy 
and local toxicity. Extravasation of some cytotoxic drugs can lead to 
catastrophic local toxicity with tissue necrosis and tendon loss (de Fraine et 
ai, 1990).
Peripheral cannulas must be changed frequently, even when meticulously 
cared for, in order to reduce the risk of infection to acceptable levels 
(Simmons 1983). Infectious complications from these cannulas are a major 
source of iatrogenic morbidity within hospitals (Arnow et a!., 1993). Because 
of the very large number of peripheral cannulas used, complications, 
particularly nosocomial infection, are a major health issue for hospital 
practice. Intravenous therapy nursing teams and other interventions aimed at 
reducing this morbidity have been instituted in a minority of hospitals in 
Australia, and may be cost effective (Collignon et a!., 1985). A similar benefit
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from dedicated nursing teams has been observed elsewhere (Weightman et 
ai, 1988; Gianino et ai, 1992).
Non-tunnelled Central Venous Catheters
When parenteral nutrition and other intensive supportive care methods 
entered widespread use between 1960 and 1970, techniques for inserting 
and maintaining polyethylene central venous catheters, inserted via 
subclavian or jugular veins, were developed. Nosocomial infection occurring 
in these critically ill patients related to the central venous catheter were 
frequently encountered (Maki et ai, 1973). To reduce this risk polyethylene 
central venous catheters have been replaced every 7 to 10 days (Daly et al.,
1981). Catheters which are "tunnelled" subcutaneously before entering a 
vein were developed to address the problem of nosocomial catheter related 
infection, allowing the long term use of a single catheter.
Recently non-tunnelled silicone rubber central venous catheters have been 
developed for long term use. These catheters are cheaper to insert than the 
tunnelled silastic catheters described below (Raad et ai, 1993A). They are 
either inserted into the subclavian vein or peripherally inserted in the 
antecubital fossa and advanced intraluminally into the central circulation (the 
so-called peripherally inserted central catheters or PICCs). When inserted 
and cared for by a dedicated hospital infusion therapy team, they have 
proved to be reasonably durable with complication rates comparable to those 
of tunnelled catheters (Slater et ai, 1985; Raad et ai, 1993A).
Tunnelled Silicone Rubber Central Venous Lines (Hickman or 
Broviac Catheters)
In 1973 the use of a tunnelled silicone rubber right atrial catheter was 
developed by Broviac et ai in an attempt to reduce infectious complications 
(Broviac et ai, 1973). This catheter was placed surgically, usually by a "cut 
down" to the cephalic vein. It was used primarily for parenteral nutrition 
(Heimbach & Ivey 1976). The small internal diameter of the catheters used 
(0.22 mm) did not allow for the infusion of thicker fluids such as blood 
products or for the easy withdrawal of blood for pathological testing.
An improvement of this catheter, designed for use in adults, and in particular 
adults with malignant disease, was described in 1979 by Hickman (Hickman 
et ai, 1979). This catheter, like the Broviac catheter was made of silicone
8
rubber, but was larger with a slightly thicker wall and a larger internal 
diameter of 0.32 mm. These catheters have achieved very wide use 
internationally and arguably represent the current standard method of 
obtaining durable intravenous access in patients receiving cancer treatment 
(Reed et al., 1989). A benefit from catheter tunnelling, in terms of reduced 
catheter related sepsis, has been demonstrated in a single small randomised 
trial (Keohane et al., 1983). In this study, the benefit of catheter tunnelling 
was apparent only when nursing care of the catheters may have been sub 
optimal.
Methods of Hickman Catheter Insertion
Surgical Open Insertion
When originally developed, Broviac and Hickman catheters were inserted 
surgically in an operating theatre under local or general anaesthesia. 
Typically, either the cephalic or internal jugular veins were isolated and the 
catheter inserted through a small incision in the vein wall. The catheter tip 
was advanced, under fluoroscopic control in Hickman's series, to the lower 
superior vena cava where it enters the right atrium. The vein wall was closed 
with a suture. Both left and right sided approaches were used. A 
subcutaneous tunnel was fashioned from the vein entry point to an exit site 
on the anterior chest wall. Several centimetres from the exit site a Dacron 
felt cuff surrounded the catheter, anchoring it, and also (presumably) forming 
a barrier against infection. Thus the features of Hickman and Broviac 
catheters which were novel in 1979 were the silicone rubber material rather 
than the usual polyethylene, the subcutaneous catheter tunnel, and the 
Dacron felt cuff proximal to the exit site. It was believed that these features 
were likely to reduce the risk of infection and allow for long term use of the 
catheter (Hickman et al., 1979). Both types of catheter continue to be widely 
used (Press et al., 1984). The smaller Broviac catheter has been used 
mainly within paediatric populations and the larger Hickman catheter in both 
children and adults (Mirro et al., 1989).
Percutaneous Insertion of Hickman Catheters
Insertion of these catheters into the central circulation by directly puncturing 
the left or right subclavian or jugular vein, using a Seldinger technique, is an 
alternative now in wide use (Mirro et al., 1990; Wisborg et al., 1991; Hughes 
et al., 1989; Kirkemo & Johnston 1982; Shulman 1982). The technique has
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the advantage of not necessarily requiring the use of operating theatre 
facilities, as an open dissection of a vein in the neck is not performed.
Percutaneous Hickman catheter insertion can be performed, under aseptic 
conditions, within an angiographic suite, using local anaesthesia (Page et ai, 
1990; Robertson et ai, 1989). Visualisation of the subclavian vein 
radiographically by performing arm venography prior to catheter insertion has 
been employed (Cockburn et ai, 1992). This allows for a secure approach to 
vein puncture and can reduce the risk of accidental arterial puncture and 
bleeding. Moreover, unexpected subclavian vein thrombosis or stenosis may 
be detected before catheter insertion is attempted, allowing the selection of 
an alternative method of obtaining venous access. As the catheter is placed, 
under fluoroscopic control, any gross malposition of the catheter tip may be 
corrected (Page et ai, 1990). However the exact position of the catheter tip 
is not known until the patient adopts an erect posture after the procedure. 
Immediate complications, such as haemothorax or pneumothorax, can be 
detected by performing a post insertion radiograph.
Similar methodology has been developed using ultrasound to provide 
sonographic guided puncture of the subclavian vein (Lameris et ai, 1990). 
Duplex Doppler ultrasound has been used to examine flow patterns within the 
jugular and subclavian veins, allowing the identification of thrombosed or 
stenosed veins unsuitable for catheter insertion (Kraybill & Allen, 1993; 
McIntyre et ai, 1992).
Hickman catheters have been successfully placed in the inferior vena cava 
with insertion via the femoral vein in circumstances where conventional 
placement in the superior vena cava was impossible (Kohli-Kumar et ai,
1992: Williard et ai, 1991).
Percutaneous insertion of Hickman catheters using a Seldinger technique 
has some potential disadvantages when compared to the surgical cut-down 
method. These include the possibility of catheter compression and breakage 
as it passes between the clavicle and first rib (Hinke et ai, 1990). There is 
also a putative increase in the risk of extravasation of infused drugs from the 
catheter due to catheter encasement in a fibrin sheath (see section 4) (Reed 
et ai, 1989; Glemlo et ai, 1988). These complications have been 
infrequently reported.
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Other Tunnelled Catheters - The Groshong Catheter
The Groshong catheter is a silicone rubber catheter of similar design to the 
Hickman catheter. It differs only in that is has a pressure sensitive two-way 
valve at the intravascular tip which prevents the entry of blood into the 
catheter unless negative pressure is applied by aspirating with a syringe to 
withdraw blood (Malviya et al., 1989). The design is aimed to reduce 
retrograde entry of blood into the catheter and therefore the need for routine 
flushing. Non-randomised comparisons have not shown measurable 
advantages over Hickman catheters (Pasquale et al., 1992; Davidson et al., 
1988).
Fully Implanted Catheter Systems - "Ports"
Hickman catheters have a permanent skin exit site which may provide a 
portal for entry of pathogens. The catheter exit site requires regular 
dressings. The external portion of the catheter can suffer accidental traction, 
causing catheter dislodgement. Hickman catheters have obvious cosmetic 
problems, particularly for children. In order to overcome these 
disadvantages, fully implantable access devices or ports were developed 
(Strum et al., 1986). The port consists of a metal injection chamber 
connected to a silicone rubber outlet catheter. The chamber can be 
punctured through a self sealing membrane of silicone rubber, using 
especially designed non traumatising needles. The catheters are inserted 
into a central vein and then connected to the port which is implanted 
subcutaneously. The membrane is punctured directly through the skin to 
obtain central venous access (Reed et al., 1989).
These devices have been shown in non-randomised studies to have a lower 
risk of infectious complications (Mirro et al., 1990; Ross et al., 1988). In a 
retrospective matched cohort study, Peques et al. demonstrated a reduced 
infection rate and time to first infection for implanted ports compared to 
Hickman catheters in adults with solid malignancies (Pegues et al., 1992).
Three small prospective randomised trials comparing Hickman catheters to 
fully implanted ports in patients with cancer have been reported (Kappers- 
Klunne et al., 1989; Carde et al., 1989; Mueller et al., 1992). In the study by 
Mueller et al., a total of 100 patients with varying forms of malignant disease 
were randomised to have either a Hickman catheter or a port inserted. 
Ninety-two patients were assessable. There were more episodes of
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unexplained fever in the implanted port group but no difference in the 
complication rate overall between the two groups. There was no difference in 
the rates of thrombotic complications. A similar study by Kappers-Klunne et 
al. in 44 patients with haematological malignancy also did not show any 
difference in infection rates. The third study by Carde et al., performed in 
100 patients with solid tumours requiring at least 6 months venous access, 
showed an prolonged time to device failure for the implanted port group 
compared to Hickman catheters. The excess in Hickman catheter loss was 
due to catheter dislodgement and to a lesser degree, infection.
The successful use of fully implanted ports has been reported in paediatric 
and adult cancer patients and in AIDS patients (Essex-Cater et al., 1989; van 
der Pijl & Frissen 1992). These ports have also been used to provide 
parenteral nutrition (Pomp et al., 1989). These devices are somewhat more 
difficult to implant, particularly in patients with haematological disease when 
post-operative bleeding can occur, and they are costly to insert, in relation to 
Hickman catheters. Hickman catheters are however, more expensive to 
maintain. The relative cost-effectiveness of these devices has not been 
elucidated. Fully implantable ports have been more readily accepted by 
children than Hickman catheters (Ross et al., 1988).
Other Methods of Obtaining Vascular Access
Other strategies used to obtain durable vascular access have included the 
use of surgically fashioned arteriovenous fistulae (Reed et al., 1982). 
Arteriovenous fistulae have not been popular for patients requiring 
chemotherapy, but are widely used for chronic haemodialysis (Reed et al., 
1989). Thrombosis and blockage are frequent problems. Hickman catheters 
were preferred in a comparative study with arteriovenous fistulae in patients 
with acute leukaemia (Wade et al., 1981)
Summary
Hickman catheters are currently the most widely used devices for obtaining 
and maintaining access to the central circulation in adults with cancer. Fully 
implantable ports are a reasonable alternative for patients without severe 
thrombocytopenia or coagulopathy at presentation. Further alternatives 
include the use of silicone rubber non-tunnelled central catheters or the use 
of peripherally inserted central catheters.
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5. HICKMAN CATHETER USE: OUTCOMES AND 
ADVERSE EVENTS
As discussed in section 4, Hickman catheters have been widely used in 
clinical circumstances where prolonged venous access is required. Settings 
where these catheters continue to be used include chronic haemodialysis, 
total parenteral nutrition, and cancer treatment. Their use has facilitated the 
development of ambulatory outpatient treatment programs and more recently 
home infusional programs (Mukau et ai, 1992). In this section the reported 
experience of Hickman catheter use and associated adverse events is 
reviewed.
Selected studies describing the use and related adverse events of Hickman 
catheters are listed in table 1. Most of these observational studies have 
included, within the study cohort, ambulatory subjects for whom some of the 
catheter care has been performed at home. The median duration of catheter 
use in these studies ranges from 30 days up to 365 days. The large majority 
of catheters have been used without major problems and then removed 
electively when no longer required, although in one study 41% of catheters 
were removed because of complications (Haywood et ai, 1990).
Hickman catheters have been well accepted by patients who appreciate the 
ease of vascular access and the avoidance of repeated venipuncture and 
needle phobia (Claessen et al., 1990). Fully implantable ports may be 
preferred particularly by children requiring repeated intravenous access 
(Ross et ai, 1988).
While the use of Hickman catheters has been an innovation in cancer 
medicine, their widespread introduction has been accompanied by significant 
adverse events and attendant morbidity. Complications reported in relation 
to Hickman catheter use include, in descending order of frequency: infection, 
central venous thrombosis, catheter blockage, catheter migration or 
dislodgement, mechanical failure or fracture, and extravasation of infused 
fluids. Acute complications of catheter insertion such as pneumothorax and 
bleeding can occur. Some rare adverse events have been reported as case 
reports. The successful use of these devices requires the development of 
strategies to minimise the incidence of complications and to ameliorate the 
impact of complications which do occur. The most important complications of 
Hickman catheter use are discussed.
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Table 1
Hickman Catheter Failure Rate and Duration Of Use
Reference N Clinical Setting Median 
Duration of 
Use in Days
Failure
Rate
Hickman et al., 1979 74 Bone Marrow 
Transplantation
NR 30%
Reed et al., 1983 106 Adult Malignant Disease 108 10%
Press et al., 1984 129 Adult Acute Non- 
lymphocytic Leukaemia
128* 19%
Harvey et al., 1986 77 Haematological
Malignancy
77 19%
Al-Sibai MB e t a i ,  1987 160 Adult Malignant Disease 131* 23%
Ross et al., 1988 41 Paediatric Malignancy 365 32%
Hughes et al., 1989 342 Adult Malignant and Non 
Malignant
30 31%
Raviglione et al., 1989 71 Adult Malignant Disease 
and AIDS
76* 17%
Claessen et al., 1990 120 Adult Malignant Disease 96 21%
Hayward et al., 1990 100 Adult Malignant Disease NR 41%
Mirro et al., 1990 266 Paediatric Malignancy NR 24%
Mueller et al., 1992 46 Adult Malignant Disease 230* 17%
Mukau et al., 1992 140 Adult AIDS and Other 129* 26%
Rizzari et al., 1992 135 Paediatric Malignancy 152* 11%
Uderzo et al., 1992 55 Paediatric BMT 111 16%
NR = Not Reported; * = mean
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Hickman Catheter Related Infection
Infection remains the most important problem associated with the long term 
use of Hickman catheters. The presence of a semi-permanent central 
venous catheter has been shown by von Hoff et al., (1990) to be a major risk 
factor for bacteraemia in children receiving chemotherapy. In their 
retrospective cohort study of children receiving chemotherapy in a single 
institution, those children with central venous catheters (Hickman or Broviac 
catheters) experienced a risk of infection 6.4-times that of children without 
catheters after controlling for other risk factors in a logistic regression model. 
These investigators found that children with central venous catheters spent 
an average of 15.4 more days per year in hospital for the treatment of 
catheter related complications, mostly infections.
In a retrospective, matched case control study conducted in a large adult 
hospital, the presence of a Hickman catheter was a major risk factor for the 
development of nosocomial candidaemia, with an estimated odds ratio of 
7.23 (Wey et al, 1989). Other identified risk factors for candidaemia in this 
study were: treatment with multiple antibiotics, prior haemodialysis, and the 
isolation of Candida species from other sites. Karabinis et al., (1988) have 
reported a retrospective case-control study in adult patients with cancer 
examining the determinants of candidaemia. Central venous catheters were 
a significant risk factor for candidaemia with a matched relative risk of 6 in 
this study when estimated using a logistic regression model.
Decker & Edwards (1988) have nominated intravascular catheter related 
infection as the major form of nosocomial infection in United States hospitals. 
It has been estimated that over 170,000 cases of nosocomial bacteraemia 
occur annually in the United States and that 50,000 of these are due to some 
form of intravascular catheter (Bryan et al., 1986). Collignon (1994), has 
recently documented the extent of nosocomial sepsis related to central 
venous catheters in Australia. He has estimated the rate of central venous 
catheter sepsis as 5.5 infections per bed year or 23 infections per 1000 
catheters purchased by the hospitals surveyed.
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Pathogenesis of Catheter Infection
Direct access to the circulation provides an easy portal of entry for 
organisms, bypassing the physical barriers to infection. Frequent use of the 
catheter for intravenous infusions, irrigations to prevent clotting in the 
catheter and blood sampling might increase access of pathogenic organisms. 
Body movements can facilitate the migration of organisms along the external 
surface of the tunnelled portion of the catheter, eventually reaching the 
circulation.
Bacterial Biofilms:
Intravascular catheters are known to develop bacterial biofilms of slime or 
glycocalyx, in which colonising bacteria, usually Staphylococcus epidermidis, 
may be observed using electron microscopy (Newman et a!., 1993). Such 
biofilms are almost universally present, even on catheters in situ for only 1 
day (Passerini et al., 1992). In long term catheters, the colonisation is on the 
luminal surface (Raad et al., 1993B). The significance of biofilms and 
bacterial colonisation of the Hickman catheters remains unclear. Adherent 
fibrin at the catheter tip may also be important. Several reports suggest 
treatment with low dose thrombolytic therapy and antibiotics may be more 
effective than the same antibiotics given alone for some patients with 
catheter related infection (Ascher et al., 1993; Jones et al., 1993). Further 
research on the significance of biofilms and fibrin as factors in catheter 
related infection is awaited.
Source of Organisms Causing Catheter Related Infection:
Infection of central venous catheters may occur with the migration of 
adherent organisms along the external catheter surface after infecting or 
colonising the skin catheter entry site. The subcutaneous tunnel and cuff of 
the Hickman catheter were designed to minimise this mode of infection. 
Alternatively, organisms may invade by migrating down the luminal surface, 
after first contaminating the catheter hub (Collignon & Munro, 1989). Careful 
protocols to prevent catheter hub contamination would be expected to reduce 
this risk (reviewed by Putterman, 1990). Catheter related infection may 
develop rarely from the infusion of contaminated fluids, sometimes as 
outbreaks due to a single contaminated source (Pegues et al., 1993).
Patients in whom Hickman catheters are inserted are often debilitated, 
immune suppressed, and frequently experience prolonged neutropenia after 
chemotherapy, enhancing the risk of infection. In these patients, particularly
16
if mucosal barriers are injured by chemotherapy, there may be translocation 
to, and colonisation of, the catheter by gut bacteria, occurring presumably 
during periods of asymptomatic bacteraemia (Tancrede & Andremont 1985).
A similar finding has been reported in children with short bowel syndrome 
and central venous catheters. In one study, 19 of 28 cases of catheter sepsis 
the offending organism was present within the faecal flora, supporting 
translocation as an important mechanism of catheter infection in this patient 
group (Kurkchubasche et at., 1992).
Pathogenic organisms may be introduced at the time of catheter insertion if a 
break down in aseptic technique occurs leading to early nosocomial infection.
Diagnosis and Definition of Catheter Related Infection
Catheter related infection can be divided into three categories based on the 
predominant site of infection. Exit site infection refers to catheter infections 
localised to the exit site. Subcutaneous tunnel infections involve that part of 
the catheter which is placed subcutaneously, before entering the circulation. 
Catheter associated bacteraemia orfungaemia implies infection involving the 
intravascular portion of the catheter or, alternatively, the intraluminal surface.
The reported incidence of catheter related infection has varied from 2.7% to 
60% (Groeger et a/., 1993). Variation between studies of the definitions of 
infection used make direct comparisons of infection rates impossible.
Press et al. (1984) have provided a set of definitions for Hickman catheter 
infections which have provided a basis for subsequent studies. Their 
definitions are given here.
Hickman catheter exit site infection: development of erythema, 
tenderness, induration, and/or purulence within 2 cm of the skin exit of the 
catheter.
Hickman catheter tunnel infection: development of erythema, 
tenderness and induration along the subcutaneous tract ("tunnel") of the 
Hickman catheter at a distance >2 cm from the skin exit site with or without 
signs of inflammation or purulence at the exit site. Insertion site infections 
(that is the site used to insert the catheter through the vein wall) involve the 
tunnel and are considered in this category.
Hickman catheter septicaemic infection: development of fever and 
bacteraemia or fungaemia in a patient with an uninflamed catheter tract in 
whom fever and bacteraemia resolve within 48 hours upon removal of the 
catheter.
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Hickman catheter septic thrombophlebitis: development of septic 
venous occlusion in proximity to the Hickman catheter associated with 
bacteraemia and fever.
The definition for catheter related sepsis has been modified by Mirro et al to 
include information from the catheter tip culture and from blood cultures 
performed on samples drawn simultaneously from the catheter and from a 
venipuncture (Mirro et al., 1989). Catheter tip culture is performed usually by 
the semi-quantitative method of Maki (Maki et al., 1977). In this method, an 
intravascular segment of the removed catheter is rolled on a sheep blood 
agar plate. The culture is considered to be positive if 15 or more colonies are 
present. Several investigators have suggested a lower cut off number of 
colonies to be significant in indicating catheter colonisation and/or infection 
of Hickman catheters (reviewed by Collignon & Munro, 1989).
Cultures of the catheter tip may provide retrospective confirmation of a 
clinical diagnosis of catheter related sepsis. Semi-quantitative cultures of 
intravascular catheters have been included in the Centers for Disease 
Control definitions for nosocomial venous infection (Garner et al., 1988). 
Similar information may be obtained by direct staining and microscopic 
examination of a catheter segment (Cooper & Hopkins, 1985). The clinical 
utility of these retrospective methods, as assessed by the degree in which 
test results effect management decisions, is low (Widmer et al., 1992).
Simultaneous peripheral and catheter blood cultures have been useful in the 
diagnosis of catheter related sepsis with high specificity (89%) but low 
sensitivity (Andremont et al., 1988). Catheter drawn specimens for culture 
are also very suitable for the diagnosis of non catheter related infections 
(Wormser et al., 1990). The definitions of Mirro et al for septicaemia and 
catheter related septicaemia extend those of Press et al. (1984) and are 
summarised here.
Septicaemia: growth of the same organism from two separate blood 
cultures or isolation of an organism from a single blood culture accompanied 
by symptoms and signs of infection.
Definite catheter related septicaemia: (1) fever and bacteraemia (or 
fungaemia) in the absence of an exit site or tunnel infection that resolved 
within 48 hours of catheter removal without alteration (or institution) of 
antimicrobial therapy; (2) organisms isolated in blood obtained from the 
catheter, but not in blood simultaneously obtained from venipuncture; or (3)
the same organism isolated from the blood and the catheter tip when the 
catheter was removed.
Quantitative blood culture techniques have been developed which allow the 
number of organisms per millilitre to be directly estimated (Yagupsky & Nolte, 
1990). Such diagnostic methods, although labour intensive, have some 
putative advantages over the conventional, broth media based method. For 
example, in Staphylococcus aureus bacteraemia from any cause, high 
bacterial colony counts are associated with a poor prognosis (Whimbey et al., 
1987; Dugdale & Ramsey, 1990). In the diagnosis of catheter related sepsis, 
the comparison of quantitative blood cultures obtained from peripheral veins 
and Hickman catheters has been studied (Fan et al., 1989). A central 
catheter to peripheral bacterial colony count ratio of greater than 7 correlated 
with a subsequent positive catheter tip culture. The sensitivity and specificity 
of quantitative paired central-peripheral blood cultures in the diagnosis of 
catheter related septicaemia remain to be defined (Yagupsky & Nolte, 1990). 
Recently it has been suggested that a central catheter to peripheral bacterial 
colony count ratio of greater than 4 should be used (Capdevila et al., 1992).
Benezra et al (1988) have incorporated quantitative paired blood cultures into 
a definition of catheter related septicaemia. In their study of 488 Hickman 
catheters, exit site infection and catheter tunnel infection were defined as 
previously described by Press et al (1984).
Catheter related septicaemia was defined as present when:
(1) positive blood cultures collected through the central venous 
(Hickman) catheter showed a 10-fold or greater colony count compared with 
peripheral quantitative blood cultures or
(2) if peripheral cultures were not collected , a colony count of 100 
colony forming units per ml or more in blood from the central catheter.
In addition, if any other clinically or microbiolically apparent source of 
bacteraemia was present then the diagnosis of catheter related septicaemia 
was not made.
New methods such as the acridine-orange leucocyte cytospin test and the 
nitroblue terazolium test have been described which may detect catheter 
related sepsis earlier than culture methods (Rushforth et al., 1993). The 
sensitivity of the acridine-orange leucocyte cytospin test may allow for a 
reduction in the number of Hickman catheters removed on suspicion of
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infection alone. This test has yet to be applied widely in studies of Hickman 
catheter related infection.
Microbiology of Hickman Catheter Related Infection
A diverse range of organisms have been associated with Hickman catheter 
related infection. Bacteria found in skin flora, particularly coagulase negative 
staphylococci and aerobic diptheriods, have become increasingly important 
as pathogens in patients with Hickman catheters in situ. These organisms, 
along with Staphylococcus aureus, have replaced aerobic gram negative 
rods as the major pathogens in catheter related infection. Table 2 lists 
organisms responsible for catheter infection from 13 combined studies 
reviewed by Clarke and Raffin (1990).
Staphylococcus epidermidis has been shown to migrate rapidly along the 
external surface of a tunnelled central venous catheter in an experimental 
model (Cooper et at., 1988). It is the most common organism causing 
catheter related infection in many studies (Clarke & Raffin 1990 and Table 2). 
Staphylococcus epidermidis has been associated with catheter related, right 
sided, endocarditis in severely immune suppressed bone marrow transplant 
recipients (Martino et at, 1990). In older studies, isolates of Staphylococcus 
epidermidis may have been erroneously discounted as contaminants.
Infection with Staphylococcus aureus has been accompanied by especially 
grave sequelae, including septic thrombosis, acute endocarditis and 
metastatic infection (George & Cornel, 1992; Raad et al., 1992). In one study 
of Hickman catheter infection due to this organism, 3 of 36 patients died due 
to progressive sepsis despite intensive treatment (Dugdale & Ramsey, 1990). 
Moreover, only 18% of these infections were cured without removal of the 
catheter. Infection involving the catheter tunnel, in particular, required 
catheter removal.
Pseudomonas species are also an important cause of catheter related 
infection in patients who are neutropenic or who suffer from AIDS. The 
majority of infections can be controlled with antibiotic therapy alone, avoiding 
catheter removal. Catheter tunnel infection with Pseudomonas aeruginosa 
has usually required catheter removal (Benezra et at, 1988). In a 
retrospective study of 584 patients with AIDS presenting over a 5 year period, 
19 bacteraemic infections with Pseudomonas species were observed, of 
which 11 were Hickman catheter related (Nelson et at, 1991). In this study,
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Pseudomonas aeruginosa was second only to Staphylococcus aureus as a 
cause of catheter related infection. Even in children with underlying HIV 
infection, the majority of catheter related Pseudomonas species infections 
can be controlled without catheter removal (Roilides et a!., 1992).
Catheter associated fungaemia is a particularly dangerous adverse event. In 
a retrospective study by Lecciones et al. (1992) of 155 episodes of catheter 
related fungaemia and cancer, the mortality rate among infected patients was 
52%. Almost all infections were due to Candida species, predominantly 
Candida albicans. The high mortality rate was observed despite aggressive 
therapy with amphotericin B and catheter removal in most patients. 
Neutropenia, usually chemotherapy related, and multiple antibiotic use were 
frequent precursors of Candida infection. In a similar study in paediatric 
cancer patients the mortality rate was 19% (Dato & Dajani, 1990). Attempts 
to retain the catheter were associated with a poor outcome.
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Table II
Spectrum of Organisms Responsible for Central Venous Catheter 
Infections (from a review of 13 studies by Clarke & Raffin, 1990)
Organism Responsible %
Coagulase-negative staphylococci 31
Staphylococcus aureus 14
Group D streptococcus 3
Other streptococci 6
Corynebacterium  species 11
Bacillus species 3
Pseudom onas species 7
Acinetobacter 3
E nterobacter species 4
Klebsiella species 4
Escherichia coli 6
Other Gram-negative 3
Candida species 7
Mixed infections 8
Other 2
Total 112
* Total is greater than 100% because of mixed infections with some authors 
reporting multiple organisms.
Putative Risk Factors for Infection
A number of potential risk factors for infection complicating Hickman catheter 
use have been identified in previous studies (including randomised controlled 
trials). The most frequently observed risk factors are summarised here.
Nature of Underlying Illness:
Many people requiring Hickman or similar semi-permanent intravenous 
catheters suffer from chronic illnesses which are associated with impaired 
immunity. Immunocompromised patients which have been observed to have 
a particularly high risk of catheter related infection include patients suffering 
from AIDS (Raviglione et al., 1989; Mukau eta!., 1992), prolonged severe 
neutropenia (Harvey et al., 1986), acute leukaemia and bone marrow 
transplantation (Groeger et al., 1993; Ranson et al., 1990).
Catheter Exit Site Dressing:
The type of dressing used over the catheter exit site may influence the risk of 
infection. Transparent semipermeable dressings have been widely used. 
They form an occlusive dressing and allow the exit site to be observed. A 
meta-analysis of 15 randomised trials comparing transparent dressings to 
conventional gauze dressings for the exit site of non-tunnelled central venous 
catheters has been reported (Hoffman et al., 1992). Transparent dressings 
were associated with an increased relative risk of infection (RR = 1.69), and 
of bacteraemia (RR = 1.63) compared to gauze dressings. Similar studies 
have not been performed with Hickman catheters.
Duration of Placement:
As would be expected, a positive relationship has been observed between 
the overall risk of Hickman catheter infection and the duration of placement 
(Fuchs et al., 1984).
Catheter Use:
The use of Hickman catheters for total parenteral nutrition has been 
observed to elevated the risk of infection when compared to other uses 
(Mulloy et al., 1991)
Single Versus Double Lumen Hickman Catheters:
Double lumen Hickman catheters are often used in situations where several 
intravenous infusions may be required simultaneously. An elevated risk of 
catheter related infection has been observed in association with double
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lumen catheters compared to single lumen catheters in retrospective non- 
randomised studies (Early etal., 1990; Henriques etal., 1993). In a 
randomised controlled trial of non-tunnelled central venous catheters used 
for total parenteral nutrition, triple lumen catheters were more frequently 
infected than single lumen catheters (Clark-Christoff et al., 1992). Similar 
randomised trials with Hickman catheters have not been performed.
Criteria for Hickman Catheter Removal for Infection
Many Hickman catheter infections can be controlled with antibiotic therapy 
without removal of the catheter and guidelines for catheter salvage have 
been suggested (reviewed by Wickham et al., 1992). In brief, most authors 
suggest removal if there is catheter related bacteraemia and no response 
after 48 hours treatment, or if there is evidence of hypotension due to sepsis, 
or evidence of septic emboli or endocarditis. Catheter removal is required for 
bacteraemia due to Bacillus species, Corynebacteriurn species and Candida 
species. Tunnel infections due to Staphylococcus aureus or Pseudomonas 
species also require the Hickman catheter to be removed. Hickman catheter 
related septicaemia can often be managed successfully, even in the 
presence of neutropenia, using parenteral antibiotics without catheter 
removal (Press et al., 1984; Newman et al., 1989; Benezra et al., 1988). The 
outcome may be improved, however, by early catheter removal when 
fungaemia or Staphylococcus aureus bacteraemia is present (Dato & Dajani, 
1990; Lecciones et al., 1992; Dugdale & Ramsey, 1990). In a prospective 
study by Benezra et al. (1988) 33 of 54 patients with catheter related sepsis 
were cured with antibiotic therapy alone, while in the remaining 21 instances 
the catheter was removed. Other studies in patients with malignant disease 
have shown catheter retention rates after antibiotic therapy of between 60% 
and 90% (Mirro et al., 1989; Press et al., 1984). Similar success rates with 
Hickman catheter retention have been reported in patients with HIV infection 
and catheter related septicaemia (Raviglione et al., 1989).
Venous Thrombosis and Hickman Catheter Occlusion
Thrombosis of any of the central veins due to Hickman catheter placement 
can cause substantial morbidity and may be, rarely, life threatening. 
Thrombosis of the superior vena cava is accompanied by clinical signs of 
bilateral engorgement of neck veins, facial swelling, and the appearance of 
collateral vessels over the chest wall. The syndrome may lead to cerebral 
oedema, coma and death. Thrombosis of the brachiocephalic vein is
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accompanied by ipsilateral swelling of the neck and arm. Thrombosis of the 
subclavian or axillary veins produces venous engorgement in the affected 
limb.
Venous thrombosis is most often detected when upper limb venograms and 
or catheter contrast studies are performed for symptoms of thrombosis or for 
catheter blockage. In studies where venograms have been routinely 
performed in asymptomatic patients, very high rates of unsuspected 
thrombosis (often incomplete) have been found. In such a study by Haire et 
al. in adults treated with autologous bone marrow transplantation, 22 of 35, or 
64%, of venograms showed evidence of thrombosis, with complete blockage 
of the subclavian vein in 10 (Haire et al., 1991). Most patients were 
asymptomatic even when the subclavian vein was completely occluded. The 
diagnosis of thrombosis may also be achieved using two-dimensional 
echocardiography supplemented with colour flow Doppler sonography 
(Hammerli & Meyer, 1993).
Hickman catheter occlusion may be complete with total obstruction of the 
catheter. More commonly however, there is simply increased resistance to 
flow. It is sometimes possible to infuse fluids through the catheter but not to 
withdraw blood, a so called "one-way catheter". Such catheter malfunction 
can afflict up to 25% of Hickman catheters (Lokich et al., 1985).
Bern et al. (1990) have conducted a randomised controlled trial of mini-dose 
warfarin to prevent venous thrombosis in adult patients with solid tumours 
and Hickman catheters. Again, routine upper limb venography was 
performed. The observation period was 90 days. In the warfarin treated 
group 4 of 42 (10%) catheters were complicated by venous thrombosis 
versus 15 of 40 (38%) catheters in the control group.
Major venous thrombosis, detected clinically or at post-mortem examination 
was found to complicate Hickman catheter placement in 17% of patients with 
solid tumour malignant disease (Anderson et al., 1989). Thrombosis may be 
accompanied by bacteraemia, which is often resistant to therapy until the 
thrombotic lesion resolves (Rupar et al., 1990).
Blood clots can be frequently aspirated from asymptomatic, normally 
functioning Hickman catheters (Anderson et al., 1987). Many of these blood 
clots presumably embolise to the lungs without complication each time the 
catheter is flushed.
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Hickman catheter related central vein thrombosis has been reported to cause 
clinical pulmonary embolus (Leiby et al., 1989: Hughes et al., 1989). 
Pulmonary embolus in this setting may be fatal (Anderson et al., 1989).
Thus, venous thrombosis is a very common accompaniment of Hickman 
catheter placement. It is often asymptomatic. The significance, clinically, of 
asymptomatic thrombosis is unclear. Catheter occlusion can occur due to 
deposition of fibrin and blood clot within the catheter lumen itself. Frequently, 
a fibrin sheath will develop over the catheter tip without any associated 
venous thrombosis. Data from a single trial suggest catheter related 
thrombosis can be largely prevented by mini-dose warfarin prophylaxis.
Pathogenesis of Hickman Catheter Related Thrombosis
Hickman catheters are constructed from a soft silicone elastomer. Catheters 
constructed from this material have been shown to have a lower risk of 
inducing thrombosis than polyethylene catheters (Pottecher et al., 1984). A 
small randomised trial comparing Hickman or Broviac catheters to polyvinyl 
chloride catheters found a thrombosis rate of 5% in both patient groups 
(Wagman et al., 1984). Thus, although an improvement upon older catheter 
designs, Hickman catheters remain thrombogenic. Platelet aggregation and 
initiation of the coagulation cascade may triggered by the catheter itself, or 
by associated endothelial damage. Infusion of some fluids including 
hypertonic parenteral nutrition solutions may initiate thrombosis (Brennan, 
1985).
Fibrin Sheath:
The formation of a fibrin sheath enveloping the distal intravascular segment 
is a frequent cause of catheter blockage. In one radiological study of 
malfunctioning Hickman catheters, an occluding fibrin sheath was present in 
57% of cases (Cassidy et al., 1987). Rarely, the enveloping fibrin sheath can 
be so extensive as to cause retrograde flow of infusate within the fibrin 
sheath to the catheter entry site with extravasation (Gemlo et al., 1988). The 
development of fibrin sheath can be detected early by measuring the 
resistance to flow within the catheter directly (Stokes et al., 1989). Catheter 
management protocols have generally included frequent bolus flushes of low 
dose heparin in order to prevent the development of intraluminal clots and 
fibrin sheaths (Fry, 1992). Despite these protocols, intraluminal blood clots 
are common, although the consequences of these in terms of rates of 
catheter blockage remain uncertain (Anderson et al., 1987)
26
The relationship of malignancy to an increased risk of thromboembolic 
diseases was described initially by Trousseau in 1865 and has subsequently 
been confirmed in many studies (Bunn & Minna, 1985). Carcinomas, 
particularly mucin producing adenocarcinomas, have the highest risk. 
Chemotherapy may contribute to a transient hypercoagulable state in 
patients with solid tumours, contributing to thrombosis risk (Levine et al., 
1988).
Putative Risk Factors for Thrombosis and Catheter Malfunction
The determinants of central venous thrombosis related to Hickman catheters 
have been less carefully studied than the determinants of infectious 
complications. Risk factors that have been observed are discussed here.
Nature of Underlying Illness:
In a study of Hickman catheters in patients with solid tumours, a diagnosis of 
adenocarcinoma of the lung was associated with the highest risk of catheter 
related thrombosis (Anderson et al., 1989). Thrombosis rates, reported from 
cohort studies where the majority of patients suffered from haematological 
disorders, are lower than those reported where the majority suffered from 
solid tumours. Such indirect comparisons suggest a higher risk of major 
thrombosis in patients with solid tumours (reviewed by Leiby et al., 1989). 
Further studies are required to test this hypothesis. Distortion of the superior 
vena cava due previous thrombotic episodes or due to large mediastinal 
tumours can elevate the risk of thrombosis.
Catheter Use:
Continuous infusions of chemotherapeutic drugs such as 5-flourouracil may 
lead to thrombosis more frequently than bolus injections through the catheter 
(Lokich et al., 1985). Use of the catheter for total parenteral nutrition may be 
accompanied by an elevated risk of thrombosis although direct evidence is 
lacking (Mughal 1989).
Position of the Catheter Tip and Site of Insertion:
In a large retrospective study of implanted ports in patients with cancer, Puel 
et al found a strong relationship between catheter tip malposition and 
superior vena cava thrombosis (Puel et al., 1993). In this study of 379 ports, 
catheters inserted from the left side, with the catheter tip placed in the upper 
half of the superior vena cava or in the brachiocephalic vein had a 28.6% risk 
of inducing thrombosis compared to 1 % for all other catheters. In a smaller
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study of both Hickman catheters and ports, catheter tip position high within 
the superior vena cava or within the brachiocephalic veins led to thrombosis 
(Stanislav et al., 1987).
Migration of the catheter tip to an unsatisfactory intravascular or 
extravascular position is discussed in the next section. Incomplete occlusion, 
with failure of blood to be aspirated may occasionally be due to abutment of 
the catheter tip against the wall of the central vein, usually the superior vena 
cava (Cassidy et a!., 1987). Improvement in catheter function can sometimes 
be obtained in these circumstances by changing the posture of the patient 
during catheter use.
Catheter Compression:
With percutaneously inserted Hickman catheters, compression of the 
catheter can occur as it passes between the clavicle and first rib prior to 
entering the subclavian vein (Aitken & Minton, 1984). Such compression can 
lead to postural catheter occlusion and, more importantly, catheter fracture, 
as discussed below.
Catheter Salvage After Central Vein Thrombosis
The traditional management of central venous thrombosis has included 
systemic anticoagulation and catheter removal (Lokich et al., 1985). Several 
investigators have demonstrated favourable outcomes with anticoagulation 
only, while maintaining the catheter in situ (Anderson et al., 1989). The local 
infusion of low dose urokinase has also been suggested to assist catheter 
salvage and to reduce morbidity from central vein thrombosis (Fraschini et 
al., 1987)
Hickman catheter occlusion, not associated with major venous thrombosis or 
catheter malposition, has been successfully relieved with low dose urokinase 
bolus injections (Anderson et al., 1987). This manoeuvre may fail in up to 
68% of cases (Monturo et al., 1990). In these resistant cases, low dose 
infusions of urokinase, streptokinase or tissue plasminogen activator have 
been successful (Haire et al., 1990: Wickham et al., 1992). Although re­
occlusion may occur, many Hickman catheters can be safely salvaged with 
these methods (Haire & Lieberman, 1992).
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Catheter Migration And Dislodgement
Despite accurate placement of a Hickman catheter, it is possible for the 
catheter tip to migrate to an unsatisfactory position, such as the internal 
jugular vein (Rasuli et al., 1992). Migration may be triggered by paroxysmal 
coughing, and has been reported as a complication of cystic fibrosis (Jacobs 
& Zaroukian, 1991). Such catheters often function poorly and are more likely 
to cause venous thrombosis (Cassidy et al., 1987). More serious sequelae 
have been reported following erosion of a vein wall by the catheter tip with 
migration to an extravascular site. Subsequent infusions through the catheter 
can lead to catastrophic extravasation of infusate (Krasna & Krause, 1991; 
Cathcart-Rake & Mowery, 1991). Lateral orientation of the catheter tip, 
abutting the vein wall, may be a precursor to extravascular migration 
(Manheimer et al., 1992).
Catheter dislodgement due to accidental traction on the external portion of 
the catheter has caused significant catheter loss, both in adult and paediatric 
populations (Carde et al., 1989). The subcutaneous Dacron cuff is not firmly 
adherent to the subcutaneous tissues for several weeks and early 
dislodgement can therefore occur. Even minor degrees of dislodgement 
might be expected to cause migration of the Hickman catheter tip to a higher 
and possibly less satisfactory position within the superior vena cava or 
subclavian veins (Cassidy et al., 1987).
Management of Catheter Migration
Migratory catheter tips can sometimes be repositioned with guide wire 
manipulation (Rasuli et al., 1992). Minor dislodgement may leave the 
catheter in a usable position, however most dislodgements or catheter tip 
migrations lead to catheter loss.
Mechanical Failure or Fracture
As Hickman catheters may be in use for many months, they are subject to 
wear and tear, and particularly to accidental puncture. Repair of damaged 
Hickman catheters with silicone adhesive and replacement hub kits is 
possible. Rarely Hickman catheters have fractured at the site of compression 
between the first rib and the clavicle, leading to embolisation of the 
intravascular portion of the catheter into the pulmonary artery (Aitken & 
Minton, 1984). Compression of the catheter can be detected on plain
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radiographs as the "pinch-off sign". A scoring system has been suggested 
(Hinke et at., 1990). Removal after a maximum of 6 months use has been 
recommended for "pinched-off" Hickman catheters (Lafreniere 1991).
Acute Complications of Hickman Catheter Insertion
The insertion procedure may be accompanied by bleeding often in 
association with accidental arterial puncture or traumatic pneumothorax. 
Although accidental arterial puncture has been reported as frequently as 6% 
of placements (Wisborg et al., 1990), significant bleeding is rare, even in 
populations with a high prevalence of coagulation disorders (Harvey et al., 
1986). Pneumothorax is also uncommon, complicating 1-5% of 
percutaneously inserted Hickman catheters (Hughes et al., 1989: Wisborg et 
al., 1990). Pneumothorax of sufficient severity to require intercostal tube 
drainage remains infrequent. Higher rates of detection of unsuspected 
iatrogenic pneumothorax can be obtained if delayed chest radiographs are 
taken (Spiliotis et al., 1992).
Venous air embolism has been reported during use or removal of central 
venous catheters as has a single instance of intra cerebral air embolism 
during insertion of a Hickman catheter (Mennim et al., 1992; Dukes et al., 
1991).
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6. METHODS
Design
A retrospective records based cohort study of consecutive Hickman catheters 
placed in a population of patients with malignant or haematological disease 
attending the medical oncology and clinical haematology units within a large 
hospital was conducted. The unit of study was each individual Hickman 
catheter successfully inserted during the study period.
Ethical Considerations
The written permission of the ACT Health Ethics Committee was obtained to 
conduct the study. Clinical records and information used during the study 
was stored securely within a medical records storage room within Woden 
Valley Hospital. A computer data file, with patient identifying information 
removed, was used within the Australian National University (in a secure 
facility) to perform part of the data analysis.
Case Ascertainment
All Hickman catheters placed during a 36 month study period, from January 
1989 to December 1991 inclusive, were identified by reviewing the clinical 
departments' records. Cross-checking of these records was performed by 
reviewing log books held in the angiography suites of the Radiology 
Department. Following the 36 month study period, study catheters remaining 
in situ were followed for a further 8 months. Data collection was performed in 
September 1992 and events included if they occurred prior to August 31, 
1992.
Catheter Eligibility
Hickman catheters were included in the study if they were placed in patients 
cared for in the Clinical Haematology & Medical Oncology Department and 
inserted percutaneously by the Radiology Department. All eligible catheters 
were placed via a subclavian approach and featured a subcutaneous tunnel. 
Fully implanted ports were not included in the study, nor were other catheter 
types such as Groshong catheters.
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Technique of Catheter Insertion
All catheters were inserted percutaneously using local anaesthesia and 
fluoroscopic control in the Radiology Department (see Section 4 for 
discussion). Placement procedures were performed by one of two consultant 
radiologists or by senior radiology registrars trained in the technique. Single 
lumen Hickman catheters were used unless a double lumen catheter was 
requested by the clinical team. Such requests were based on the expectation 
of a requirement for more than one intravenous infusion concurrently. The 
site of insertion (left or right) was chosen by the radiologist performing the 
placement. The inserting radiologists generally preferred the right sided 
approach although left sided catheters were freely inserted if preferred by the 
patient. The right sided approach was considered relatively contraindicated if 
previous surgery had occurred within the right shoulder region or if a right 
subclavian vein catheter had been used in the past. In these circumstances 
the left sided approach was used.
The insertion method has been described (Cockburn eta!., 1992; Page et a/., 
1990; Robertson et a!., 1989). The procedure was performed with the patient 
supine. Under aseptic conditions, a stab incision was made at the entry site 
below the junction of the lateral and middle thirds of the clavicle. The 
subclavian vein was punctured with a Chub needle and J-wire inserted, over 
which a peel-away sheath was introduced. The subcutaneous track was 
created with a tunnelling instrument (Heyd & Rosser, 1991). The catheter 
length was determined by laying it along the line on of the j-wire using 
fluoroscopy, with the aim of leaving the catheter tip at the right atrial-superior 
vena cava junction. The catheter was then filled with saline containing 
heparin and inserted through the peel away sheath and positioned with 
fluoroscopic control. Catheter function was assessed immediately after the 
procedure. The catheter exit site was covered with a semi-permeable 
transparent dressing (OpsiteR). An erect posterioanterior chest radiograph 
was taken after insertion to check the final position of the catheter tip and to 
exclude the immediate complications of pneumothorax and haemothorax.
Catheter Use and Care
There were no specific restrictions on clinical use of the catheters during the 
study period. Hickman catheters were used to infuse intravenous drugs and 
fluids including cytotoxic chemotherapy, blood products, and parenteral 
nutrition as required. Blood samples for testing were routinely drawn from
32
the catheter. All use of the catheter for treatment or blood sampling was 
performed by Registered Nurses trained in the technique. Following use, the 
catheter was flushed with 5 mis. of normal saline containing 50 units of 
heparin, and "locked" with the same solution.
When not in regular use, Hickman catheters were flushed at least weekly.
The catheter exit site was dressed with a transparent semi-permeable 
dressing weekly. Although all use of the catheter for treatment or blood 
sampling was performed by professional nurses, some catheter care, 
including exit site dressings and catheter flushes, was performed by the 
patient or by a family member. Patients and family members performing such 
catheter care were trained by hospital nursing staff, and generally supervised 
by trained Community Nurses.
Management of Hickman Catheter Complications
Formal protocols for the management of catheter complications were not in 
place within Woden Valley Hospital during the study period. Catheter related 
infections were managed with antibiotics. Catheter removal was ordered by 
the responsible clinician if the infection seemed severe and unlikely to 
respond to antibiotic treatment. Other complications were likewise treated as 
determined by the clinician in charge. Specimens for microbiological testing 
were taken only if there was clinical evidence of infection. Blood for culture 
was obtained from the catheter and concurrently from a peripheral 
venipuncture in circumstances where catheter related septicaemia was 
suspected. Swabs of the catheter exit site were taken for culture to 
investigate signs of exit site infection and also to investigate febrile illnesses. 
Quantitative blood cultures were not performed during the study period. The 
Hospital policy required all Hickman catheters removed for any reason to be 
referred for semi-quantitative tip culture. Semi-quantitative catheter tip 
cultures were performed according to the method of Maki et al. (1977).
Data Collection
Information was extracted retrospectively from each patient's medical record. 
All records were examined independently by me and one of two 
collaborators. In instances where a difference of interpretation of the clinical 
record occurred, the record was further reviewed conjointly by both of the 
investigators concerned and a consensus reached. Individual data forms 
were completed for each catheter. For each catheter, data were collected
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relating to the patient's age, gender, height, weight, diagnosis, and treatment. 
Details of the catheter placement procedure, and of catheter use and 
complications were also collected. The operator inserting the catheter (one 
of two interventional radiologists or an advanced trainee in radiology) was 
recorded. The patient was considered to be an inpatient if admitted to a 
hospital for at least 24 hours prior to catheter insertion.
Radiological Review
All post-placement radiographs were reviewed by one collaborating 
radiologist. All radiological reviews were performed without knowledge of the 
catheter outcome.
An assessment of the degree of compression of each catheter, as it passed 
between the first rib and the clavicle, was made according to the methods of 
Hinke et al. (1990). A catheter was graded as grade 0 if it ran a smooth 
curved course in the region of the clavicle and first rib with no narrowing. 
Grade 1 catheters showed a degree of bending or deviation from a smooth 
curved course but no luminal narrowing. Grade 2 catheters showed luminal 
narrowing as the catheter passed beneath the clavicle. Grade 3 has been 
defined as complete catheter fracture.
The position of the catheter tip was directly measured on the chest 
radiograph using the carina as the reference point. The distance of the 
catheter tip inferior to the carina was measured and recorded in centimetres. 
Thus a catheter which ended at the carina was recorded as zero cm. The tip 
position of catheters which ended superior to the carina within the upper 
superior vena cava were recorded as negative numbers. A satisfactory 
position was believed to be 2 cm or more inferior to the carina (see Figure 1). 
In the analysis, a catheter tip with a measured position of 2 cm or more was 
defined as lying within the right atrium or low superior vena cava, whereas a 
catheter tip with a position of less than 2 cm was defined as being in the high 
superior vena cava (Figure 2).
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Figure 1
Chest radiograph showing a right sided Hickman catheter with catheter tip ending 
within the superior vena cava; the measurement of the catheter tip position relative 
to the inferior margin of the carina is demonstrated.
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Case Definitions
The following definitions of outcomes were applied during data collection. 
Obesity
The Quetelet body mass index (BMI) was calculated for each patient 
according to the formula: BMI = weight /{height)2 where the weight is given
in kilograms and the height in meters. A patient was considered to be obese 
if the BMI was greater than or equal to 30 (Truswell, 1981).
Catheter Related Infection
The rationale for these definitions was discussed in Section 5. Exit site 
infection was defined as pain, tenderness, erythema or purulent exudate 
within 2 cm of the exit site. Tunnel infection was defined as pain, tenderness 
or erythema along the subcutaneous course of the catheter > 2 cm from the 
exit site. Septicaemia was defined as growth of an organism from 2 or more 
separate blood cultures or as growth from a single culture with signs and 
symptoms of sepsis. Catheter related septicaemia was defined as (1) 
septicaemia in the absence of an exit site or tunnel infection which resolved 
within 48 hours of removing the catheter without the addition of antibiotic 
therapy; (2) positive culture of blood drawn from the catheter but with a 
simultaneous negative blood culture obtained from venipuncture; (3) the 
same organism cultured from blood and from the catheter tip after catheter 
removal. Catheters with infection at multiple sites were scored as separately 
infected for each individual site.
Central Vein Thrombosis
The diagnosis of an episode of central vein thrombosis was based solely on 
the findings of upper limb venography. Thrombosis was said to be present if 
there was complete or near complete obstruction of the axillary or subclavian 
veins or of the superior vena cava by thrombus detected by venography. 
Venography was only performed in response to a clinical suspicion of 
thrombosis or catheter occlusion.
Hickman Catheter Occlusion
Catheter occlusion was defined as the inability to infuse fluids through the 
catheter or to aspirate blood from the catheter.
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Catheter malfunction included all cases of catheter occlusion as well as 
catheters where fluids could be infused but through which blood could not be 
aspirated, that is, the so-called "one-way" catheters.
Hickman Catheter Migration or Dislodgement
Catheter migration was diagnosed when the catheter tip was found to have 
moved to an unsatisfactory position on radiographs or when the catheter 
either spontaneously or accidentally was completely or partially removed.
Hickman Catheter Failure
Catheter failure was defined as removal or loss of the Hickman catheter due 
to a complication in circumstances where there was a continuing need for 
intravenous access. Acceptable evidence of a continuing requirement for 
intravenous access was the placement a further semi-permanent device, or 
the use of peripheral intravenous cannulas for infusions, within 28 days of 
catheter removal.
Acute Complications of Catheter Placement
Pneumothorax and haemothorax were recorded when reported on the post 
insertion chest radiograph. Bleeding and haematoma after catheter 
placement was recorded if described in the medical record.
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7. STATISTICAL METHODS
Data relating to each catheter were stored in a database using a personal 
computer. After the data were checked an initial descriptive analysis was 
performed. Statistics describing patient and catheter characteristics and the 
frequency of adverse events were calculated using the Epi Info version 5.1 
computer program (Dean et al., 1990). The median duration of catheter 
placement was calculated as was the frequency of catheter infection per one 
hundred catheter days.
Analysis of time to catheter failure, and time to the development of catheter 
malfunction were performed using the product limit method of Kaplan and 
Meyer (Lagakos, 1992). In this analysis, catheters electively removed, lost to 
follow-up, or in use at the time of final analysis, without an event of interest 
having occurred, were considered to be censored observations. Catheters 
remaining in situ at the time of patient death were similarly censored.
A univariate assessment of potential risk factors for catheter failure was 
conducted. In this analysis, only the initial catheter inserted for any one 
patient was considered. Prospectively determined factors to be assessed 
were patient gender, diagnostic group (leukaemia versus non-leukaemia), 
obesity, site of catheter insertion, catheter tip position, and the operator 
inserting the catheter. The relative risk of failure in each group in the cohort 
(as defined by the risk factor in question) was calculated and Taylor Series 
95% confidence intervals (Cl) provided. The null hypothesis of no 
relationship existing between the factor and catheter failure was tested using 
Fisher's Exact test (Zelterman & Louis, 1992). A probability of less than 0.05 
was considered sufficient to reject the null hypothesis. Two tailed tests were 
used throughout. A similar analysis, using the same factors, was performed 
to assess the determinants of catheter malfunction.
A secondary analysis was performed to assess potential risk factors for 
catheter related infection. Factors examined were gender, diagnostic group 
(leukaemia versus non-leukaemia), obesity, the number of catheter lumens 
(one versus two), and the operator inserting the catheter. Finally an analysis 
of risk factors for catheter migration or dislodgement was performed. Factors 
examined were patient obesity, site of insertion and the operator performing 
the insertion. Again, 95% confidence intervals for the relative risk were 
constructed and proportions compared with Fisher's Exact test. As the
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number of comparisons was limited and the analysis prospectively defined a 
correction for multiple comparisons was not applied.
Separate time to failure curves for groups within the cohort were constructed 
using gender, catheter site, operator and obesity. These curves were 
compared using the logrank test (Lagakos, 1992). A probability of less 0.05 
was considered sufficient to reject the null hypothesis using a two-tailed test. 
Time to malfunction curves were similarly constructed and tested using 
catheter site and catheter tip position as factors.
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8. STATISTICAL METHODS - MULTIVARIATE
The time to Hickman catheter failure was modelled in a multiplicative Cox 
proportional hazards model (Cox & Oakes, 1984). In order to ensure that 
each catheter analysed was fully independent, the analysis was performed 
only on the initial catheter placed in any one patient. Second or subsequent 
catheters, in a single patient, were thus excluded. The factors examined in 
the initial analysis, with the exception of obesity and catheter tip position, 
were added to the model in a stepwise procedure and their influence 
assessed by calculating the reduction of deviance (or the likelihood ratio 
statistic). The body mass index and the catheter tip position in centimetres 
were modelled as continuous explanatory variables rather than as factors. 
Explanatory variables and factors were retained in the model if the reduction 
of deviance was greater than would be expected by chance. The null 
hypothesis of no reduction in deviance was rejected at a probability of less 
than 0.05.
Parameters were calculated using a personal computer and the EGRETR 
computer program (Epidemiological Graphics, Estimation and Testing 
package, version 0.26.6; Sere & Cytel, 1991). The adequacy of the fitted 
model was assessed by examining the delta-beta residuals graphically and 
found to be adequate. The assumption of proportional hazard was checked 
by examining the effect of adding an interaction term including log time for 
each significant explanatory variable, to the final model (EGRET Manual, 
revision 4, page 204).
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9. RESULTS
Patient and Catheter Characteristics
Over the 3 year study period there were 153 Hickman catheters provided for 
122 patients. There was also 1 Groshong catheter inserted and 24 ports 
implanted. Of the 153 Hickman catheters inserted, 1 catheter was excluded 
because of insertion via the femoral vein and 2 were excluded because the 
medical records were not available for review.
A total of 150 catheters placed in 120 patients therefore were available for 
inclusion in the study cohort.
The patient characteristics are summarised in Table III. The mean patient 
age was 49.5 years (range 14 to 78). At the time of final analysis, eight 
months after the end of the study entry period, 62 patients (56%) had died of 
their underlying disease and 48 (44%) were alive.
The details of catheter insertion and use for all study Hickman catheters are 
summarised in Table IV. The right subclavian approach was chosen for 
catheter placement for 69% of all catheters (73% of catheters where the site 
of insertion was recorded). When second or subsequent Hickman catheters 
inserted in the one patient are excluded, right sided catheters were more 
strongly preferred, representing 77% of catheters inserted (92 of 120). Of the 
30 replacement catheters inserted during the study period 17 (57%) were left­
sided. The reason for selecting the right or left site for insertion was not 
usually recorded in the clinical record.
Most Hickman catheters inserted were double lumen catheters, reflecting the 
anticipated complexity of the planned intravenous therapy.
Only 10% of the catheters were used for total parenteral nutrition (TPN). As 
might be expected in this patient population, the major use of the catheters 
was for some form of chemotherapy.
Although these catheters are easily inserted in the outpatient setting, the 
large majority (77%) of recipients were inpatients at the time of catheter 
insertion.
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Table III
Patient Characteristics 
N=120
Demography
Male 64 53%
Female 56 46%
Age 49.5 years (mean)
Body Mass
Obese 18 15%
Non-obese 102 85%
Disease
Leukaemia 22 18%
Lymphoma 27 23%
Solid tumour 58 48%
Other* 13 11%
* Other = multiple myeloma 3, myelodysplasia/AML 6, HIV/Kaposi 1, 
vasculitis 1, DVT 1, aplastic anaemia 1.
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Table IV
Characteristics of Hickman Catheter Insertion and Use
N=150
Site of Insertion
Right 103 69%
Left 38 25%
Unknown 9 6%
Number of Catheter Lumens
Single lumen 32 21%
Double lumen 117 78%
Unknown 1 1%
Parenteral Nutrition
TPN 15 10%
No TPN 135 90%
Use for Chemotherapy
Chemotherapy 110 73%
No chemotherapy 40 27%
Initial or Replacement Catheter
First catheter 120 80%
Second 21 14%
Third or more 9 6%
Status at Time of Insertion
Inpatient 115 77%
Outpatient 35 23%
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Table V
Number of Hickman Catheters Per Patient
N=120
Number of catheters Patients
1 99 81%
2 16 14%
3 2 2%
4 2 2%
5 1 1%
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Of 120 patients in the study, 99 had only one catheter inserted, while 21 had 
2 to 5 catheters inserted during the study period (Table V). Second or 
subsequent catheters were more likely to be inserted via the left side (92/120 
versus 17/30; Fisher's Exact p<0.001) and were more frequent in patients 
with leukaemia (16/38 versus 14/112; Fisher's Exact p=0.001). There were 
no differences in the number of catheter lumens or in the use to which the 
catheter was put between initial and replacement catheters (data not shown).
Outcome of Catheter Placement
Findings of Radiological Assessment
Post insertion chest radiographs were available for review for 140 catheters. 
The mean distance of the catheter tip as measured inferior to the carina was 
2.39 cm (standard deviation 2.5, range 16 to 11 cm). The was no difference 
in the mean catheter tip position for the three operators inserting catheters.
Radiographs were interpretable regarding catheter compression for 138 
catheters. There was no compression of 101 catheters (73%), grade 1 
compression of 28 catheters (20%) and grade 2 compression of 9 catheters 
(7%). Grade 1 or 2 compression was more frequent with left sided catheters 
(16/38 versus 21/98; Fisher's Exact p=0.02). Despite the observed frequency 
of catheter compression, there were no reported instances of catheter 
fracture within the study cohort.
Acute Complications of Flickman Catheter Placement
Acute complications were rare and mild. There was a single occurrence of 
accidental arterial puncture which was not accompanied by significant 
bleeding or other sequelae. One episode of exit site bleeding was recorded 
in a patient with acute myeloid leukaemia and disseminated intravascular 
coagulation. One occurrence of tunnel haematoma was also encountered. 
Neither of these complications lead to significant morbidity or to catheter loss. 
Traumatic pneumothorax was not observed during the whole study period. 
Also, no case of previously unrecognised pneumothorax was observed during 
the radiological review of all available post insertion chest radiographs.
Outcome of Catheter Use
The median time until catheter removal for any reason was 55 days (range 1 
to 650). The total duration of use for all catheters was 14,225 patient days.
Study catheters remained in situ at the time of the death of 42 patients (28% 
of all catheters). Five catheters (3% ) were lost to follow up due to patient 
transfer to another institution after a median observation period of 27 days 
post insertion (range 14 to 148). A total of 103 catheters were actually 
removed within Woden Valley Hospital. Complications led to the non­
elective removal (or catheter failure, as defined) of 48 catheters (32% of all 
catheters). The remaining 55 catheters (37%) were removed electively when 
intravenous access was no longer required. Thus 68% of catheters remained 
functional until regular intravenous access was no longer required, the 
patient was lost to follow up, or died with the catheter in situ. There were no 
patient deaths recorded related to any catheter complication.
Catheter Failure
Hickman catheter failure occurred on 48 occasions or 32% of all catheters. 
The causes of catheter failure were as follows: infection or suspected 
infection in 22 catheters (46% of failures), blockage or malfunction with or 
without venous thrombosis in 18 catheters (37%), and catheter migration or 
dislodgement in 8 (17%). The features and determinants of these specific 
adverse events are discussed in later sections.
The determinants of overall catheter failure were examined. A univariate 
analysis of potential risk factors for catheter failure was performed. Male 
gender was associated with a relative risk of catheter failure of 2.02 
compared to female gender (95% confidence interval 1.13 to 3.6, Fisher's 
Exact p=0.017). Left sided catheter insertion was associated with a relative 
risk of 2.3 compared to right sided insertion (95% confidence interval 1.12 to 
3.55, Fisher's Exact p=0.057). The other potential risk factors examined, 
including obesity of the catheter recipient, were not associated with an 
increased risk.
The duration of catheter use without failure was examined using product limit 
survival curves. The time to failure for all 150 study catheters is shown in 
Figure 3. The actuarial median time to failure was 176 days. Survival curves 
were constructed for identified risk groups using only data from the 120 initial 
Hickman catheters inserted. The median time to failure for initial catheters in 
males was 162 days versus 308 days for females (logrank p=0.026, Figure 
4). Curves for right and left sided catheters are shown in Figure 5. The 
median time to failure was 170 days for left sided catheters and was not 
reached for right sided catheters (logrank p=0.098).
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Cox multiplicative proportional hazards models for time to catheter failure 
were constructed. A series of models including potential risk factors were 
examined in a stepwise procedure as described in the methods section. 
Significant predicting factors of the time to catheter failure included in the 
final model were:
FACTOR HAZARD RATIO
Insertion site (R vs L) 2.2
Gender (M vs F) 2.4
BMI (body mass index) 1.1
95% CIs.
1.03 & 4.76 p=0.041 
1.16 & 4.92 p=0.019
1.03 & 1.18 p=0.005
The hazard ratio for the BMI may be interpreted as the ratio of hazard of 
catheter failure experienced by each catheter per each unit increase in the 
index, controlling for the other factors in the model. The BMI was included in 
the model in units of kilograms per meter2.
The patient diagnostic group, the operator inserting the catheter, the number 
of catheter lumens and the catheter tip position were not predictors of time to 
catheter failure in this model.
The Cox survival analysis confirmed the site of insertion and patient gender 
as predictors of reduced time to catheter failure. The model also showed BMI 
to be independently associated with early catheter failure, even though the 
univariate analysis failed to show an association between obesity and the 
overall failure rate. The mechanism of catheter failure associated with these 
risk factors is explored in following sections describing specific types of 
complication.
Hickman Catheter Related Infections
Catheter related infections were common, complicating 40 catheters (27%). 
Many of these infections were mild. However 18 catheters were lost due to 
infection and a further 5 were removed when infection was suspected but 
subsequently not proven. Thus a total of 23 catheters (15%) failed due to 
infection or suspected infection during the study period. There were, overall, 
0.28 catheter infections per 100 catheter days.
Exit site infections
Signs and symptoms of Hickman catheter exit site infection were recorded in 
relation to 33 catheters (22%). They were generally managed with antibiotics
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and/or local toilet with frequent dressing changes. There were 8 catheter 
failures (5% of all catheters) due to exit site infections alone. Of the 33 
infected catheter exit sites 26 occurred in 120 initial catheters, the remainder 
(7) occurring in replacement catheters.
Risk factors for exit site infection:
In an examination of the 120 initial catheters, male gender was associated an 
increase in exit site infections, with a relative risk, male versus female, of 2.6 
(95% Cl 1.2 to 5.4, Fisher's Exact p=0.014). When all 150 catheters were 
included in the analysis the relative risk, male versus female was 2.3 (95% Cl 
1.2 to 4.2, Fisher's Exact p=0.02). The was no relationship present between 
the other factors examined and the risk of exit site infection.
Microbiology of exit site infection:
Catheter exit site swabs were submitted for microbiological examination at 
least once for all 33 recorded exit site infections and also for 23 exit sites 
where infection had not been recorded. The latter exit site swabs were taken 
as part of the routine investigation of fever. The microbiological culture 
findings were not part of the definition of exit site infection applied in this 
study. Of 50 cultures taken from 33 exit sites with clinical signs of infection, 
20 cultures (from 13 catheter exit sites) were reported as showing coagulase 
negative staphylococci only. These organisms were also present in 14 of 33 
cultures from 23 non-infected catheter exit sites. As coagulase negative 
staphylococci are normal skin commensal bacteria, the significance of the 
detection of these organisms in this site (as distinct from blood or catheter tip 
cultures) is uncertain. Four clinically infected sites were culture negative 
including 1 catheter which was removed for exit site infection. The culture 
results from infected sites are summarised in Table VI and from non infected 
sites in table VII. No clearly pathogenic organisms were obtained from non 
infected sites, and the utility of this routine investigation in febrile patients is 
uncertain.
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Table VI
Microbiological Isolates From Hickman Catheter Exit Sites Where 
Infection Was Clinically Present
N=33*
Coagulase neg. 13 39%
staphylococci
Staphylococcus aureus 11 33%
Candida species 2 6%
Pseudomonas aeruginosa 2 6%
Group D streptococcus 2 6%
Corynebacteria 1 3%
Enterobacter 1 3%
Serratia 1 3%
* A total of 33 isolates were obtained from 33 clinically infected exit sites. 
Although 4 clinically infected exit sites did not yield any organisms, 4 
clinically infected exit sites returned 2 organisms; a total of 50 examinations 
were performed on the 33 exit sites.
Table VII
Microbiological Culture Results From Hickman Catheter Exit Sites 
Where Infection Was Clinically NOT Present
N=23A
Coagulase neg. 10 44%
staphylococci
Corynebacteria 1 4%
No growth 12 52%
A A total of 33 examinations were performed on 23 catheter exit sites.
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Staphylococcus aureus was only recovered from clincaily infected exit sites. 
This organism was the most important single cause of exit site infection. The 
exit site cultures from the 8 catheters removed because of isolated exit site 
infection returned Staphylococcus aureus from 3, Pseudomonas species from 
2, and coagulase negative staphylococci from 2. As noted previously, 1 
culture was negative.
Subcutaneous tunnel infections
Three subcutaneous tunnel infections were observed with an overall 
incidence of 2%. One infection was mild and culture negative. The 2 other 
infections were severe, in both instances requiring removal of the catheter 9 
days after insertion. In one patient blood cultures grew Staphylococcus 
aureus and Candida albicans and in the other the catheter tip culture was 
positive for coagulase negative staphylococci.
Hickman catheter related septicaemia
Catheter related septicaemia, as defined, complicated 11 Hickman catheters 
(7%) in 8 patients and led to the removal of 7 catheters (5%). A further 5 
catheters were removed for suspected catheter related sepsis with negative 
blood cultures. In 2 of these instances the catheter tip semi-quantitative 
culture was positive, suggesting a significant infection may have been 
present. The microbiological isolates from blood cultures taken from patients 
with catheter related sepsis are summarised in Table VIII.
Table VIII
Microbiological Isolates from Blood in Catheter Related
Septicaemia
N=11
Coagulase neg. 
staphylococci
5 45%
Staphylococcus aureus 3 27%
Corynebacteria 1 9%
Serratia 1 9%
Micrococcus 1 9%
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Exactly half of the patients who suffered from catheter related septicaemia 
complicating their initial Hickman catheter had underlying acute leukaemia. 
The diagnosis of acute leukaemia was the only identified risk factor for 
catheter related sepsis (relative risk leukaemia versus non-leukaemia = 3.11, 
95% Cl 1.4 to 7.0, Fisher's Exact p=0.036).
Catheter tip culture results:
Semi quantitative culture of the catheter tip was performed on 73 of 108 
removed catheters including 20 of 22 catheters removed for proven or 
suspected catheter related infection. The microbiological isolates from these 
cultures are summarised in Table IX. Again both coagulase negative 
staphylococci and Staphylococcus aureus were prominent pathogens in this 
setting. These two organisms were cultured from 65% of catheters removed 
for suspected or proven infection. They were also found infecting or at least 
colonising 25% of catheter tips sent for routine surveillance culture. Four 
catheter tips yielded cultures of Staphylococcus aureus even though they 
were not removed because of infection. In 3 of these instances there was a 
documented exit site infection due to Staphylococcus aureus present, which 
may have allowed contamination of the catheter tip to occur at the time of 
elective catheter removal.
Overall the data relating to catheter infection reveal a high incidence of 
significant infection due to gram positive organisms, generally coagulase 
negative and coagulase positive staphylococci.
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Table IX
Microbiological Isolates from Hickman Catheter Tip
Catheters removed for suspected or proven infection
N=20*
Coagulase neg. 8 40%
staphylococci
Staphylococcus aureus 5 25%
Corynebacteria 1 5%
Serratia 1 5%
no growth 5 25%
Catheters removed for reasons other than infection
N=53A
Coagulase neg 9 17%
staphylococci
Staphylococcus aureus 4 8%
no growth 40 75%
* A further 2 catheter tips were not submitted for examination.
A A further 28 catheter tips were not submitted for examination.
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Venous Thrombosis and Hickman Catheter Malfunction
Some form of catheter blockage, thrombosis or malfunction was observed to 
complicate 44 catheters (29% of all catheters).
Venous Thrombosis
Clinical signs of major thrombosis were observed in 4 patients; 2 developed 
the syndrome of superior vena cava obstruction and 2 developed ipsilateral 
arm swelling. Upper limb venography or catheter contrast radiographs were 
performed in response to catheter malfunction or signs of venous obstruction. 
An example of a contrast catheter radiograph demonstrating venous 
thrombosis is provided in Figure 6. Venous thrombosis, confirmed 
radiologically with these methods, was seen complicating 12 Hickman 
catheters (8%). No patient developed venous thrombosis on more than one 
occasion. Most cases of venous thrombosis were managed by catheter 
removal (10 of 12 affected catheters). Two catheters were salvaged with 
infusions of low dose streptokinase. Heparin anticoagulant therapy was 
instituted in 7 of 12 patients with thrombosis. All patients recovered from the 
episode of thrombosis without long term sequelae.
One patient with a subclavian vein thrombosis developed dyspnoea and 
hypoxaemia 2 days after venography and catheter removal. A 
ventilation/perfusion lung scan showed several perfusion defects without 
matching ventilation defects, strongly suspicious of pulmonary embolism. No 
other site of venous thrombosis was clinically apparent. The patient made a 
full recovery following treatment with systemic anticoagulant therapy.
Potential risk factors for venous thrombosis examined were insertion site, 
catheter tip position, patient gender, and diagnosis of the underlying disease. 
Only data relating to the initial catheter for each patient was included. For 
left sided catheters the risk of thrombosis was 19% compared to 5% for right 
sided catheters (relative risk left versus right 4.38, 95% Cl 1.19 to 16;
Fisher's Exact p=0.038). No increase in the risk of venous thrombosis was 
observed due to the other factors examined.
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Figure 6
Hickman catheter venogram showing thrombus encasing the catheter tip within the 
superior vena cava.
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Hickman Catheter Malfunction
Catheter malfunction was a frequently encountered phenomenon, affecting 
44 catheters (29%). The malfunctions ranged from intermittent difficulty in 
aspirating blood through the catheter to complete blockage associated with 
major venous thrombosis. All 12 catheters complicated by venous 
thrombosis had some degree of malfunction. The majority of these catheters, 
7 of the 12, were completely blocked. A total of 18 catheters (12%), including 
10 of the 12 catheters associated with venous thrombosis, were lost due to 
these complications.
Of 44 catheters observed to malfunction, 10 became completely blocked 
while 34 were partially blocked, with difficulty or inability to aspirate blood. 
Nine of the blocked catheters were removed and replaced because of 
blockage and/or associated venous thrombosis. Thrombolytic therapy with 
low dose streptokinase was attempted with 3 of the blocked catheters, but 
resulted in catheter retention on only 1 occasion.
There were 34 (23%) partially blocked or "one-way" catheters. This form of 
malfunction was often intermittent. On investigation with contrast studies 5 of 
these partially blocked catheters were associated with venous thrombosis. 
Nine partially blocked catheters were eventually removed and replaced 
because of persisting poor function or associated venous thrombosis. Low 
dose streptokinase was administered successfully to clear a single catheter.
The relationship between Hickman catheter malfunction in the initial catheter 
inserted into each patient and potential risk factors was examined. No 
difference in the risk of malfunction was observed due to patient gender, the 
presence of obesity, patient diagnostic group or the operator inserting the 
catheter. Of the initial catheters where the site of insertion was recorded, 10 
of 21 (48%) left sided catheters developed malfunction compared to 17 of 75 
(23%) right sided catheters (relative risk of left versus right 2.58, 95% Cl 1.38 
to 4.8, Fisher's Exact p<0.01). Moreover 6 of 21 (29%) left sided catheters 
actually failed because of catheter blockage/malfunction compared to only 5 
of 92 (5%) right sided catheters (relative risk of left versus right 5.26, 95% Cl 
1.8 to 16, Fisher's Exact p=0.005). The number of excess catheter failures 
due to blockage of left sided catheters is sufficient to account for the overall 
increase in catheter failure observed for left sided catheters.
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The position of the catheter tip, as measured on post insertion erect 
radiographs, was defined as lying within the high superior vena cava if it was 
less than 2 cm inferior to the carina. Catheter malfunction occurred in 14 of 
40 (35%) high position catheters compared to 14 of 73 (19%) low position 
catheters (relative risk high versus low catheter position 1. 8 , 95% Cl 0.97 to 
3.43, Fisher's Exact p=0.07).
Some form of malfunction was more frequently encountered with double 
lumen catheters compared to single lumen catheters. When the initial 
catheter inserted in each patient only is considered there were 2 of 25 (8%) 
cases of malfunction for single lumen catheters versus 29 of 95 (31%) double 
lumen catheters (relative risk double lumen versus single lumen of 3.81, 95% 
Cl 1.0 to 15, Fisher's Exact p=0.02). There was no difference in the risk of 
venous thrombosis comparing single to double lumen catheters nor in the risk 
of complete catheter blockage. The excess catheter malfunction observed 
with double lumen catheter was due to partial catheter blockage, that is, the 
inability to aspirate blood. Of 25 single lumen catheters there were no 
instances of reported isolated partial catheter obstruction, although there 
were 2 single lumen catheters which became completely obstructed. This 
experience compares with 24 of 95 (25%) double lumen catheters in which 
isolated partial blockage developed (Fisher's Exact p<0.01). The marked 
increase risk of catheter malfunction due to partial blockage in double lumen 
catheters did not lead to any increase in frequency of catheter failure and 
replacement. Partial catheter blockage or failure to aspirate was assigned 
when either lumen of a double lumen catheter was observed to be 
malfunctioning as recorded in the medical record. The presence of two 
lumens in a catheter might be expected to increase the risk of an lumen 
specific event simply because there is twice the number of lumens to 
malfunction, relative to the single lumen catheter. Specific information about 
the functional state of each catheter lumen was not available. Flowever, even 
when the frequency of partial catheter obstruction is calculated per lumen 
(rather than per catheter), there remains an excess risk with double lumen 
catheters (15% versus 0, Fisher's Exact p=0.048). This method may 
underestimate the risk per lumen in double lumen catheters, as it assumes 
that no catheter was observed to develop partial obstruction of both lumens 
simultaneously.
A Cox proportional hazards survival analysis was performed with the time to 
first occasion of catheter malfunction of any kind as the endpoint of interest.
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A series of models including potential risk factors were examined in a 
stepwise procedure as described in the methods section.
Patient age, gender and type of underlying disease were not significant 
predictors of time to malfunction and were excluded from the model. The 
catheter tip position and the operator inserting the catheter were likewise 
omitted. Predictors of reduced time to catheter malfunction included in the 
final model were:
FACTOR HAZARD RATIO
Insertion site (R vs L) 3.5
BMI 1.1
Lumens (1 vs 2) 6.9
95% Cl
1.5 to 8.3 p=0.003
1.0 to 1.2 p=0.041
0.92 to 52 p=0.06
The hazard ratio for the BMI may be interpreted as the ratio of hazard of 
malfunction experienced by each catheter per unit increase of the BMI. The 
BMI was included in the model in units of kilograms per meter2.
The Cox survival analysis confirmed the insertion site and the number of 
catheter lumens as important predictors of catheter malfunction. Additionally, 
the BMI was identified as a predictor of malfunction, even though obesity 
(that is, a BMI greater than 30) was not associated with malfunction in the 
univariate analysis. In this analysis, the catheter tip position was no longer a 
predictor of time to malfunction when the site of insertion, the BMI, and the 
number of lumens were controlled.
Hickman Catheter Migration or Dislodgement
Migration of the catheter tip to an unsatisfactory position, and or accidental 
dislodgement of the catheter was observed to complicate 11 catheters (7%). 
On 2 occasions dislodgement was due to the accidental complete removal of 
their Hickman catheter by confused patients. On 2 other occasions the 
catheter tip migrated spontaneously to the neck, from an initially satisfactory 
position within the superior vena cava. Both these catheters were able to be 
salvaged with the catheter tip being manipulated with a guide wire into an 
acceptable position. One catheter became dislodged, with the subcutaneous 
cuff fully extruded from the exit site. This partially retained catheter was able 
to secured in place with dressings and to be used until intravenous access 
was no longer required. Eight of the 11 catheters observed to migrate or
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become dislodged were eventually lost because of this complication (5% of 
all catheters).
Patient obesity (as defined) was associated with an increased risk of catheter 
migration/dislodgement (relative risk obese versus non-obese 4.5, 95% Cl 
1.34 to 15, Fisher's Exact p=0.03). No other factor examined was associated 
with an increased risk of catheter migration/dislodgement.
Four of 18 initial Hickman catheters inserted into patients with a BMI greater 
than 30 were observed to suffer migration or dislodgement. All these 
catheters were removed because of this complication. Of the 5 catheters 
which migrated or were dislodged in non-obese patients, 3 were removed.
For all 150 study catheters, 11 cases of catheter failure in obese patients 
were observed. Catheter migration or dislodgement was the major cause of 
failure in this patient group, accounting for the loss in 5 of the 11 failed 
catheters, compared to 3 due to infection and 3 due to blockage. Among the 
126 catheters inserted in non-obese patients only 3 were removed because 
of migration or dislodgement. The excess risk of catheter failure observed in 
obese patients is thus predominantly due to the risk of migration or 
dislodgement experienced by this patient group.
There was no difference in the observed frequency of catheter migration of 
dislodgement between groups defined by patient diagnosis (leukaemia 
versus non-leukaemia), catheter insertion site (right versus left) or the 
operator inserting the catheter. The position of the catheter tip as measured 
on the post insertion chest radiograph also did not predict ultimate catheter 
migration.
Type of Vascular Access Used After Hickman Catheter Failure
Of the total cohort of 150 study catheters placed in 120 patients, there were 
48 catheter failures. The definition of catheter failure implied the ongoing 
need for vascular access following catheter removal. The type of vascular 
access device employed after Hickman catheter failure was recorded for 45 
catheters. A replacement Hickman catheter was inserted on 21 occasions 
(47%) for 16 patients. Standard peripheral cannulas were used on 22 
occasions (49%) and fully implanted ports were placed on 2 occasions (4%).
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10. DISCUSSION
This study describes the experience of Hickman catheter use in one centre 
caring for a mixed population of patients within a combined haematology and 
medical oncology service. Catheter care and maintenance protocols were 
uniform across the patient population. The catheter insertion technique was 
also uniform. Although there were no formal protocols in place during the 
study period for the management of catheter related complications, the same 
physicians cared for patients in all diagnostic groups and presumably applied 
similar clinical decision making rules to each catheter. The study therefore 
offers an opportunity to gain insight into Hickman catheter use, adverse 
events, and the determinants of adverse events in a setting which should be 
applicable to a wide range of haematology or medical oncology hospital 
departments.
Impact of the Study Design
The retrospective study design required the use of existing clinical records. 
The study was thus able to be completed relatively quickly despite a cohort 
enrolment period spanning 3 years. A minimum follow up period of 8 months 
was also feasible because of the retrospective design.
A retrospective design is associated with a number of disadvantages when 
compared to prospective studies. The main source of information was the 
patient medical record. These were completed to varying degrees of quality. 
Information relating to adverse events was primarily derived from this source. 
Particularly in regard to infection and poor function, the description of the 
catheter related events provided in the clinical record was critical in 
determining these study outcomes. Information was recorded in these 
records by both medical and nursing staff.
Given that the clinical records were completed by hospital staff without 
consideration of their possible use in this study there are potential errors in 
determining catheter outcomes. Possible sources of bias will be discussed in 
relation to each individual study endpoint.
Some potentially important putative risk factors for Hickman catheter 
complications could not be studied because insufficient information was 
available. In particular, the patient functional status was not recorded for 
majority of catheter recipients at the time of catheter insertion. Although
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post-insertion chest radiographs were performed after all catheter insertions, 
these were not available for review for 10 of 150 catheters. In these cases 
the radiographic films either missing within the Hospital or had been removed 
to other institutions.
The retrospective study design may have some advantages over prospective 
studies. As discussed by Ransom et al. (1989) the act of enrolling a patient 
into a prospective study may influence the attitude of professional staff to 
catheter care and act to minimise complications during the study period.
Such an effect has been observed by Wagman et al. (1984) who reported a 
reduction in the incidence of catheter related infection when a randomised 
controlled trial was commenced. In this respect, a retrospective study has 
the advantage of obtaining information in an environment of standard 
catheter care. Thus the results of a retrospective study should be more 
readily generalised to standard "non-trial" practice.
Hickman Catheter Failure
Catheter failure was defined in such a way as to minimise the potential for 
misclassification. Thus catheter failure was recorded only if removal 
occurred because of any perceived or real complication and if there was 
subsequently clear evidence of a continuing requirement for vascular access. 
A Hickman catheter being maintained "just in case" clinical circumstances 
arose where it might be needed (for example, a patient who has just achieved 
a complete remission but in circumstances where early relapse is possible) 
would not be classified as a failure if its removal was triggered by a 
complication and a subsequent intravenous infusion was not required within 
28 days. The determination of catheter failure is therefore robust within the 
study.
The Hickman catheter failure rate of 32% observed in this study falls within 
the upper range of failure rates reported from comparable studies (see table 
I, page 14). The median duration of catheter use of 55 days is similarly 
comparable.
Multiple insertions of Hickman catheters were frequent during the study 
period (see Table V, page 45). Not all of these insertions were required 
because of catheter failure, some catheters being removed electively and 
then replaced when a further indication for durable intravenous access arose.
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The repeated need for catheter insertions due to catheter failure represents a 
significant burden for the patients involved as well as additional cost.
Many complicated Hickman catheters can be salvaged with appropriate 
treatment. The overall failure rate is dependant not only on the frequency and 
severity of catheter complications, but also on the clinical management of 
these complications. Catheter removal is warranted if it shortens the duration 
of the catheter related illness or reduces the risk of important sequelae. As 
will be discussed, catheter removal may have been undertaken more 
frequently during this study than in some prospective studies because of the 
absence of explicit guidelines for the treatment of catheter infection and poor 
function or thrombosis.
Hickman Catheter Related Infections
The most frequently observed complication of Hickman catheter use in this 
study was infection. Catheter related infections were observed to complicate 
27% of all catheters. The majority of infected catheters exhibited exit site 
infection (33 of 40 infected catheters).
There were 0.28 infections observed per 100 catheter use days. This rate is 
somewhat higher than the rate of 0.137 per 100 catheter days given by 
Clarke & Raffin (1990) in their review of the results from 51 studies with a 
total experience of 694,842 total catheter use days. A number of individual 
studies have reported equivalent or higher infection rates than were observed 
here (for example Press et al., 1984; Raviglione et at., 1989; Groeger et al., 
1993). Comparison of infection rates between studies is difficult because of 
the lack of uniformity of the definitions of infection and because of the 
different patient populations studied.
Exit Site Infection
Exit site infection represented a much larger proportion of all catheter related 
infections in this study than has been observed elsewhere. In the 
prospective study by Benezra et al. (1988), for example, only 34 of 142 
episodes of infection in 488 catheters were due to exit site infections. Similar 
ratios of exit site infections to other forms of catheter related infection have 
been reported by Pegues et al. (1992), Groeger et al. (1993) and Raviglione 
et al. (1989). In a review by Press et al. (1984) including 17 studies, 45% of 
all infectious complications were exit site infections, 20% were tunnel
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infections and 34% were catheter related septicaemia. Thus the proportion 
of exit site infections observed in the current study (33 of 40 infections or 
82%) is greater than expected.
Exit site cultures performed when clinical infection was observed showed a 
preponderance of gram positive organisms (see Table VI, page 53), 
particularly Staphylococcus aureus (30%) and coagulase negative 
staphylococci (35%). A similar preponderance of staphylococci has been 
observe in other studies of exit site infection (Groeger et ai, 1993).
The determination of catheter exit site infection was based on the description 
of clinical signs recorded in the clinical record. In this study the notation 
within the clinical record of any degree of erythema, exudate, or tenderness 
was sufficient to lead to the designation of exit site infection. It is possible 
that the recording of trivial erythema at the catheter site by clinical staff could 
have lead to an excessive determination of cases of exit site infection. The 
nursing staff caring for these catheters routinely observed the exit site on a 
daily basis and exhibited a high index of suspicion for catheter related 
infection. The frequency of catheter related infection may therefore have 
been overestimated in this study because the retrospective study design and 
the broad clinical definition of exit site infection used.
A potential bias may result from the effect of regular observation of catheter 
exit sites for patients cared for as inpatients within the Hospital compared to 
the relatively infrequent observation of catheters in ambulatory patients with 
Hickman catheters being cared for at home. Patients with leukaemia, in 
particular, are more likely to be treated as inpatients.
These data show that exit site infection was a significant clinical problem, 
leading to substantial catheter loss in the study population. The frequency of 
exit site infection was higher than has been generally reported. The 
increased incidence of exit site infection was responsible for the somewhat 
high overall rate of infection per 100 catheter days of 0.28.
Subcutaneous Tunnel Infection
Only 3 subcutaneous tunnel infections were observed. These infections were 
somewhat less frequent than observed in other studies (for example Benezra 
et ai, 1988). Two of these infections occurred very early after insertion 
suggesting insertion technique may have been important. Both of these
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catheters were lost. Most studies have shown a poor salvage rate of 
Hickman catheters with subcutaneous tunnel infection. The limited data from 
this study are consistent with these findings.
Hickman Catheter Related Septicaemia
In this study, catheter related septicaemia was observed to complicate 11 
catheters of which 7 were removed. In addition a further 5 catheters were lost 
for suspected infection. As discussed in Section 5 (page 24), the outcome 
from catheter related septicaemia may improve in some circumstances with 
early catheter removal, particularly when fungaemia or Staphylococcus 
aureus infection is present.
Only 3 of the 12 catheters removed because of proven or suspected catheter 
related septicaemic infections in this study were infected with Staphylococcus 
aureus. There were no episodes of catheter related fungaemia leading to 
catheter failure. Thus, although the incidence of catheter related septicaemia 
was relatively low in the study cohort, the outcome in terms of the number of 
Hickman catheters which failed, is disappointing. Arguably 9 of the 12 
removed catheters were potentially salvageable, although probably not all of 
the infections would have responded adequately to antibiotic therapy with the 
catheter in situ. An assessment of the adequacy of the treatment given for 
catheter related sepsis is beyond the scope of this study. There were no 
deaths observed due to catheter related septicaemia. Although the numbers 
of catheters involved is small, it is possible that the removal of some of these 
catheters may not have significantly contributed to the resolution of the 
catheter-related infection. Possible premature removal of Hickman catheters 
because of suspected infection has been noted by Stansilav et al (1987) in a 
retrospective study.
The microbiological isolates from blood (Table VIII, page 56) and from 
Hickman catheter tips (Table IX, page 58) demonstrate the extremely 
important role of gram positive organisms in catheter related septicaemia.
Not surprisingly, the widespread use of the devices has been associated in a 
shift in the distribution of causative organisms in patients with neutropenic 
sepsis towards coagulase negative and positive staphylococci (Lazarus et 
al., 1983; Gibson et al., 1994).
Venous Thrombosis and Hickman Catheter Malfunction
Malfunction or thrombosis were observed to complicate 29% of all catheters, 
a slightly higher complication rate than was observed due to infection.
Bagnall et al. (1989) in their study in a paediatric population, reported an 
incidence of catheter malfunction of 31 %. In adults with solid tumours, 
similar rates of malfunction have also been observed (Cassidy et al., 1987).
Venous thrombosis was detected complicating 8% of catheters. The 
frequency of thrombosis observed elsewhere has ranged from 2.6% to 14% 
in studies where upper limb venography was only performed when patients 
were symptomatic or when the catheter was malfunctioning (Cassidy et al., 
1987; Johnston et al., 1989; Beers et al., 1990; Puel V et al., 1993).
One patient within the study cohort suffered from clinically apparent 
pulmonary embolism after developing catheter related subclavian vein 
thrombosis. The true incidence of pulmonary embolus due to Hickman 
catheter related thrombosis remains uncertain (Leiby et al., 1989).
Eighteen catheters were lost because of malfunction or thrombosis compared 
to 23 catheter failures due to suspected or proven infection. Thus 
malfunction and thrombosis were major complications in the study cohort in 
terms of catheter loss. All detected cases were symptomatic or had poor 
catheter function. For patients with thrombosis of a major vein, the catheter 
was usually removed and intravenous heparin therapy provided. Attempts 
were made to salvage blocked catheters with the passage of intraluminal 
wires and, on 4 occasions, streptokinase therapy. Urokinase was not used 
during the study period. Some of the 8 catheters which failed due to 
blockage in the absence of venous thrombosis may have been successfully 
salvaged with more frequent exhibition of low dose thrombolytic therapy.
Local infusions of urokinase or tissue plasminogen activator may speed the 
resolution of venous thrombosis and permit retention of perhaps one half of 
the associated catheters (Fraschini et al., 1987; Rodenhuis et al., 1993). 
Some authors recommend removal of catheters in the presence of 
symptomatic venous thrombosis (Hill & Berry, 1990). This was the practice 
followed during the present study, with the exception of 2 Hickman catheters 
treated with, and salvaged by, streptokinase infusions.
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Hickman Catheter Migration or Dislodgement
Eleven catheters were complicated in this way and 8 (5% of all catheters) 
were lost. Thus although migration or dislodgement was a relatively 
infrequent event, catheter failure due to these complications was important. 
Other studies have shown similar rates of catheter failure due 
dislodgement/migration (Reed et al., 1983; Harvey et al., 1986; Hughes et 
al., 1989). Dislodgement is a frequent cause of failure of Hickman catheters 
in paediatric populations, particularly among very young children (Mirro et al., 
1990).
In this study, 2 catheters were lost soon after insertion because of accidental 
dislodgement in patients who were confused due to delirium related to their 
underlying illness. The occurrence of these complications emphasises the 
need for vigilance in the care and use of these catheters in order to minimise 
the risk of accidental loss.
Other Complications of Hickman Catheter Insertion and Use
Only very infrequent and mild acute complications of catheter placement 
were observed. Pneumothorax complicating catheter insertion was not 
observed in this study despite rates of up to 7.5% reported in other studies 
also using a percutaneous insertion technique (Lameris et al., 1990). Only 1 
instance of accidental arterial puncture was observed. Similar studies have 
observed accidental arterial puncture rates of up to 6% (Wisborg et al.,
1990). Extravasation of infused drugs was also not observed during the 
study period, although a case of severe cytotoxic drug extravasation due to 
back-tracking of infusate around a Hickman catheter has subsequently been 
reported from Woden Valley Hospital.
Patient Diagnosis and Hickman Catheter Complications
The nature of the malignant disease for which the Hickman catheter is placed 
has been shown in a number of studies to influence outcome. Patients with 
acute leukaemia or other disorders in which prolonged neutropenia is 
frequently seen, such as after autologous bone marrow transplantation, have 
been observed to suffer higher rates of catheter related septicaemia (Press et 
al., 1984; Ranson etal., 1989; Groeger et al., 1993). Patients with solid 
tumours, particularly carcinomas, have been reported to experience higher 
rates of catheter thrombosis (Anderson et al., 1989).
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In the current study, the diagnosis of acute leukaemia was associated with a 
relative risk of catheter related septicaemia of 3.11. The severity and 
duration of neutropenia was not assessed within this study, however patients 
with acute leukaemia receiving induction chemotherapy routinely experience 
substantially more intense neutropenia than patients with solid tumours or 
lymphoma. The Hickman catheters in such patients might be expected to be 
used more frequently than in patients without acute leukaemia, reflecting the 
intensity of supportive care, including blood product infusions, employed in 
this group. Mucositis is also a common accompaniment of intense leukaemia 
induction therapy, possibly increasing the risk of translocation of an infecting 
organism to the catheter. Data describing the severity of mucositis and the 
relative frequency of catheter use were not available in this study. Acute 
leukaemia was not associated with an increased incidence of exit site or 
catheter tunnel infection.
The excess of Hickman catheter related sepsis was not accompanied by an 
excess risk of catheter failure in patients with acute leukaemia. The 
diagnosis of acute leukaemia was not associated with a shorter time to failure 
in a Cox proportional hazards model.
The patient diagnosis was not related to the risk of catheter related 
thrombosis or catheter malfunction in this study. Patient diagnostic group 
was likewise not a significant predictor of time to malfunction in the Cox 
proportional hazards model.
Patient Gender
A previous study of Hickman catheter use has associated male gender with 
Hickman catheter infection (Claessen et al., 1990). In the current study male 
gender was associated with a relative risk of exit site infection of 2.6. Male 
gender was not associated with any observed increase in risk of catheter 
related septicaemia, or of catheter malfunction, thrombosis or dislodgement. 
The observed excess risk of exit site infection led to an excess of catheter 
failures in male patients. Male gender was associated with a relative risk of 
catheter failure of 2.02. The time to catheter failure was shorter for male 
patients, and this was confirmed in a Cox proportional hazards model of time 
to catheter failure.
The majority of previous studies have not identified gender as an 
independent risk factor for Hickman catheter complications. In this study it
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was specifically exit site infection which was observed more frequently in 
male patients, and this effect was sufficiently strong to lead to a substantial 
increased risk of catheter failure, even when potential confounding factors 
such as disease group and obesity were controlled in a Cox multivariate 
model.
The way in which male gender caused the observed increase in exit site 
infection is unclear. Reed et al (1983) have suggested physical activity may 
cause the collection of fluid under semipermeable dressings (as used in the 
study cohort) and that this process may lead to exit site infection. Perhaps 
ambulatory male patients were more likely to be physically active. It is also 
possible that the standard of catheter care varied on the basis of gender. 
Some catheter care was performed at home by a relative of the patient, often 
the spouse, after a period of instruction by professional staff. This form of 
care occurred when a suitable carer was available. Anecdotally, this was 
most often the female carer of a male patient. One can speculate that female 
patients may have received better catheter care simply because their male 
spouses was not so readily trainable to replace professional community 
nurses. Data relating to the identity of the person performing catheter care 
was not collected as part of this study. There is ample evidence to suggest 
that the quality of nursing care is a major determinant of catheter related 
infection (Keohane et al., 1983). The adequacy and frequency of Hickman 
catheter exit site care should be carefully followed in quality assurance 
programs and future studies of catheter related infection.
Obesity
In this study the presence of obesity, as defined, was associated with a 
relative risk of catheter migration/dislodgement of 4.5. Anecdotal reports of 
catheter migration or dislodgement in obese patients exist (Heyd & Rosser, 
1991). Similarly, loss of Hickman catheters has been reported due to 
pendulous breasts (Moorman et al., 1987). The migration is almost certainly 
due to mechanical factors related to the subcutaneous tunnel. The Hickman 
catheters were inserted with the patient supine. The catheter is tethered by 
the Dacron subcutaneous cuff. In obese patients, if the catheter is not very 
carefully placed, the catheter tip is simply withdrawn from the superior vena 
cava when the patient stands after insertion. Due to the relatively mobile 
subcutaneous tissues of obese patients the catheter remains, throughout its
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life, at a greater than normal risk of catheter tip migration to an unsatisfactory 
position.
Obesity was not associated with an increased risk of infection in this study, 
although this has been reported elsewhere (Newman et al., 1993). No 
increase in the risk of catheter malfunction due to obesity was observed. 
Despite the increased risk of catheter migration/dislodgement observed, 
there was no overall increase in the risk of catheter failure in obese patients. 
However, in the Cox proportional hazards model, the body mass index was a 
statistically significant predictor of time to catheter failure. A hazard ratio for 
catheter failure of 1.1 for each unit increase in body mass index when 
insertion site and gender were controlled was observed. In a similar 
proportional hazards model for time to poor function, body mass index was 
also a statistically significant predictor variable.
The findings in this study suggest an important increase in risk for adverse 
outcomes from Hickman catheters as the body mass index rises. This risk 
factor for Hickman catheter complications has not been widely studied to 
date. Possibly some of the complications observed may have been 
preventable with more careful selection of the catheter exit site by the 
inserting operator. However, it appears that Hickman and other catheters 
which feature a subcutaneous tunnel may be less useful devices in obese 
patients. In particular, non tunnelled non cuffed catheters may be preferable 
in these circumstances. Further studies of the influence of body mass index 
and central venous catheter complications should be undertaken to extend 
the findings in this study. The measurement of body mass index in future 
prospective studies of central venous access devices is recomended.
Site of Catheter Insertion and Catheter Tip Position
The selection of the left subclavian vein for Hickman catheter insertion, rather 
than the right side, was associated with a relative risk of venous thrombosis 
of 4.38. There was also an elevated risk of catheter malfunction. A 
suggestion that thrombotic complications may follow left sided catheter 
insertion was initially made by Brown-Smith et al. (1990). Puel et al. (1993) 
have reported a high incidence of venous thrombosis in patients with left 
sided catheters where the catheter tip was inadvertently positioned high in 
the superior vena cava. The current study confirms and strengthens these 
findings.
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Catheter malfunction was somewhat more common in this study when the 
measured catheter tip position was high within the vena cava. The time to 
malfunction was also shorter when catheters ended high within the superior 
vena cava. However, when catheter position was entered into a Cox 
proportional hazards model for time to malfunction it was not a significant 
explanatory variable with insertion site, body mass index, and the number of 
catheter lumens controlled. Venous thrombosis was not more frequent in 
patients with "high" catheters. Although the findings are suggestive, this 
study does not necessarily support the findings of Stanislav et al. (1987) 
where high catheter tip position did lead to venous thrombosis.
The insertion site (left versus right) was not associated with an increased risk 
of infection or migration. Left sided insertion was associated with a relative 
risk of catheter failure of 2.3. The excess of catheter failure for left sided 
insertions was due to thrombosis. The insertion site was a significant 
predictive factor for time to catheter failure and time to catheter malfunction in 
both Cox proportional models used in the study.
Left side catheters follow a more acute arc within the left subclavian vein, 
innominate vein, and upper superior vena cava than right sided catheters. 
This leads to the catheter tip abutting the lateral wall of the vena cava (Figure 
7). Irritation of the intima of the vena cava by the catheter and by irritant 
infusates could lead to platelet aggregation and the initiation of thrombosis. 
The influence of catheter insertion site might be expected to vary depending 
on the position of the catheter tip within the superior vena cava of right 
atrium. No interaction between these factors was detected within this study, 
although the number of initial left sided catheters was small (only 21) and 
such a relationship is not excluded.
The results of this study suggest that left sided Hickman catheters should be 
avoided if possible. Based on the study of Puel et al. (1993), left sided 
Hickman catheters, if inserted at all, should be positioned so that the catheter 
tip is within the right atrium in order to reduce the risk of venous thrombosis. 
Insertion site is an important factor requiring control in any future studies of 
catheter related thrombosis.
Double Lumen Catheters
Single lumen Hickman catheters have been observed to have a lower rate of 
infection when compared to double lumen catheters is several retrospective
studies (for example Henriques et ai, 1993). In the current study the number 
of catheter lumens was not a risk factor for any form of catheter related 
infection.
Catheter malfunction was more frequently observed in this study with double 
lumen catheters. Moreover the number of catheter lumens was predictive of 
time to catheter malfunction in a Cox proportional hazards model. The risk of 
venous thrombosis was not increased with the use of double lumen 
catheters. The study design did not allow for the assessment of the function 
of each lumen in double lumen catheters. Double lumen catheters have a 
greater external diameter than single lumen catheters and this could be factor 
in the formation of a fibrin sleeve at the catheter tip, leading to malfunction 
(Horattas et ai, 1988).
Based on the results of this study and others, double lumen Hickman 
catheters should be avoided unless the provision of more than one lumen is 
essential.
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11. CONCLUSIONS
The observed median duration of catheter use of 55 days and the catheter 
failure rate of 32% are similar to the findings of other studies of Hickman 
catheter use. Adverse events were more frequent among individuals with 
high body mass index, among males and in patients with leukaemia. Left 
sided catheter insertion was associated with a high risk of thrombosis and 
should be avoided if possible.
The results emphasise the need for the judicious use of these devices, 
particularly for the high risk groups. Non-tunnelled catheter types may be 
preferable for obese people to reduce the risk of catheter displacement. The 
need for explicit protocols for catheter maintenance and use, and also for the 
management of complications is apparent. Special emphasis and advice 
regarding exit site care should be given to male patients. Maximal sterile 
precautions during catheter use are justified for patients with leukaemia.
Further research, aimed at refining practice in this area should be 
undertaken. Newer intravascular devices, such as non tunnelled silastic 
catheters, and antibiotic impregnated cuffs should be tested, preferably in 
randomised trials. Studies on the relative cost-effectiveness of fully 
implanted ports are also required. Prophylactic antibiotics at the time of 
insertion or as regular "flushes" require careful evaluation, particularly in view 
of the potential risk of stimulating microbial resistance. Such studies will 
provide the stimulus for improvement to be made in the management of 
patients requiring durable venous access. Based on the findings of this 
study, the patient's BMI, gender, and the site of catheter insertion should be 
recorded, along with the underlying disease type, in new studies of Hickman 
or similar catheters.
This study, with others, demonstrates the imperfection of the currently 
available devices and methods. In people with a major illness such as 
cancer or leukaemia, Hickman catheter complications may seem to be mostly 
only of nuisance value. Clinicians easily underestimate the frequency and 
severity of these types of adverse events. Prospective studies of a selected 
"series" of patients in which a new device or technique is tested tend to 
systematically underestimate the risk of adverse events which will be 
observed when the technology is subjected to general, non-trial, use. The 
adverse events observed in this study, particularly nosocomial catheter
infection and catheter related thrombosis, form part of a silent epidemic of 
iatrogenic illness which has accompanied the transfer of new intensive 
medical therapies into general use.
Ongoing, high quality, institutional surveillance of the complications of these 
devices should be seen a part of standard care in patients with malignant 
disease. Such surveillance would then become a criterion for any proposed 
accreditation process developed for institutions treating cancer.
Consolidation of information across a group of collaborating institutions might 
be expected to lead to the timely identification of group wide trends and also 
of problems occurring within a single treatment centre. Such a program could 
lead to a greater dividend in terms of quality of life and cost savings than 
many technologically complex clinical innovations under current 
investigation.
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ADDENDUM
1. Clinical pulmonary embolus and Hickman catheters:
In this study only one patient was observed to develop a clinical pulmonary 
embolus which may have been associated with Hickman catheter related 
thrombosis. Clinical pulmonary embolus was therefore observed to complicate 
0.7% of all Hickman catheters.
2. Adherence to protocols for Hickman catheter insertion and care:
Protocols were in place during the study period for the insertion and care of 
Hickman catheters. Adherence to these protocols was not assessed in the 
study due to the lack of available data in the records reviewed.
3. Definition of catheter related septicaemia:
The definition of catheter related septicaemia was modelled on that of Mirro et 
al. (1989). Cases of septicaemia were considered catheter related if they 
occurred: (1) in the absence of an exit site or tunnel infection which resolved 
within 48 hours of removing the catheter without the addition of antibiotic 
therapy; OR (2) with a positive culture of blood drawn from the catheter but with 
a simultaneous negative blood culture obtained from venipuncture; OR (3) the 
same organism cultured from blood and from the catheter tip after catheter 
removal. These presence of signs of infection at a distant site did not exclude 
catheter related septicaemia. This definition has been widely applied, 
particularly in retrospective studies. Some studies, such as Benezera et al. 
(1990) have excluded cases of septicaemia where there are signs of infection at 
a distant site. These studies have been prospective and have usually employed 
quantitative blood culture methods. It is possible that the definition of Mirro et al. 
might lead to an over estimate of the frequency of Hickman catheter related 
septicaemia. It was not possible to estimate the size of this effect (if any) from 
the current study.
4. Association between catheter infection, nature of pathogen and concurrent 
antibiotics or distant infection:
Due to the nature of the data sources used for the study accurate data 
describing distant infection and antibiotic use were not available. The 
association could not, therefore, be examined in this study.
5. Increased incidence of Gram positive infection in patients with neutropenia:
In this study, and others, Gram positive organisms account for more than 50% of 
pathogens causing Hickman catheter related infection. As Hickman catheters 
and similar devices have been used more widely in patient populations at risk for 
neutropenia, there has been a trend towards Gram positive organisms becoming 
more frequent pathogens in this group. This trend has been documented 
recently in Australia (Gibson et al., 1994).
